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The overall objective of this dissertation was to further elucidate alterations in 
vascular function with age in healthy humans by utilizing the passive leg movement 
(PLM) model, with and without a posture-induced increase in femoral perfusion pressure 
(FPP), to assess nitric oxide (NO) bioavailability. In the first study, we examined the 
central and peripheral hemodynamic responses to PLM in young and old women.  We 
observed a two- to three-fold attenuation in the leg blood flow (LBF) and leg vascular 
conductance (LVC) responses to PLM in the old women compared to the young women. 
These findings indicate that, similar to men, aging significantly attenuates vascular 
function in healthy women. The second study investigated the possible impact of elevated 
physical activity and fitness on the attenuated vascular function with age.  Utilizing PLM, 
we documented that older individuals who remained physically active displayed 
improved vascular function compared to their sedentary age-matched counterparts, 
although not achieving the same vascular function as young sedentary individuals. In this 
study, we took these findings one step further by examining elite endurance trained older 
subjects and found that while they too demonstrated improved vascular function 
compared to sedentary age-matched subjects, vascular function failed to be restored to 
the level observed in the young, suggesting that there may be a ceiling effect whereby 
increasing physical activity yields diminishing returns in terms of vascular health. The 
third study sought to determine the role that oxidative stress may play in the age-related 
 attenuation in vascular function by administering both a placebo and an oral antioxidant 
cocktail (AOC) in a single-blind cross-over design.  In the placebo condition, the old 
subjects once again had an attenuated vasodilatory response to PLM. Although displaying 
greater inflammation than the young, the old did not clearly exhibit elevated markers of 
oxidative stress or decreased markers of antioxidant defenses. The AOC significantly 
improved antioxidant status and decreased lipid peroxidation in both the young and old. 
However, the AOC had no effect on the vasodilatory response to PLM in either group. 
Therefore, vascular dysfunction persisted in the older adults despite an AOC-induced 
increase in antioxidant status and attenuated oxidative stress, questioning the role of 
redox balance in the apparent age-related decrease in PLM-induced vasodilation. 
Collectively, this research has provided significant insight into the impact of aging in 
women, physical activity, and oxidative stress on alterations in NO-mediated vascular 
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CHAPTER 1 
INTRODUCTION 
Cardiovascular disease (CVD) is the number one cause of morbidity and mortality 
in the United States and other developed nations (10). Each day, more than 2,150 
Americans die of CVD, accounting for 1 out of every 3 deaths per year. Aging is a major 
risk factor for CVD. Indeed, the average annual rate of first cardiovascular events 
increases 25-fold between the ages of 40 and 90 years. The impact of aging on CVD 
progression depends, at least to some extent, on the health and function of the vascular 
endothelium and, specifically, bioavailability of the endothelium-derived vasodilator 
nitric oxide (NO) (21, 23). NO has been demonstrated to be antiatherogenic (25), and NO 
bioavailability is lower in populations with hypertension (34), hyperlipidemia (3), 
diabetes (41), and heart failure (16), as well as with age (1, 7, 44). 
In the vasculature, NO is an endothelium-derived vasodilator that is synthesized 
by endothelial nitric oxide synthase (eNOS) in response to a variety of stimuli, such as 
increased wall shear stress, cellular deformation, and estrogen (Figure 1.1). Activation of 
eNOS by the calcium-calmodulin complex allows oxygen, NADPH, and L-arginine to be 
converted to water, NADP+, L-citrulline, and NO. Importantly, the production of NO can 
be up regulated or down regulated by the phosphorylation of eNOS at various stimulatory 
or inhibitory phosphorylation sites. NO then diffuses into the adjacent vascular smooth 
muscle cells and, through a cyclic GMP-dependent pathway, leads to a fall in 
intramyocellular calcium levels, smooth muscle cell relaxation, and vasodilation. 
Coupled with its antiatherogenic properties, this makes NO one of the most important 
molecules in the maintenance of vascular function and health. Although it is recognized 
that NO bioavailability declines with advancing age, currently, the mechanisms 
responsible for this fall in NO bioavailability and subsequent attenuation in vascular 
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function with age are not fully understood. However, evidence suggests that two possible 
mechanisms, the adoption of a sedentary lifestyle (39) and increased vascular oxidative 
stress (51), may play a role. Additionally, the literature regarding vascular function in 
women is far less extensive than that focused upon men; therefore, alterations in NO 
bioavailability with age in the female population remains poorly characterized. 
Premenopausal women have a reduced risk of CVD compared to men and 
postmenopausal women. This observation has led to the belief that young women possess 
some sort of inherent cardioprotection. Estrogen, which declines drastically from pre- to 
postmenopause, has been documented to have powerful vascular effects, and may help 
explain the lower CVD risk in young women. Indeed, postmenopausal women display 
significantly attenuated endothelium-dependent vasodilation compared to premenopausal 
women (2, 14). This attenuated vascular function in postmenopausal women can be 
reversed by estrogen replacement therapy (14, 20), implicating diminished estrogen 
content as the primary cause of vascular dysfunction in old women. Furthermore, in mice, 
ovariectomy to simulate the postmenopausal decrease in estrogen significantly attenuates 
endothelium-dependent vasodilation, which can be restored by exogenous estrogen 
supplementation (24, 32).  
The mechanisms by which estrogen provokes this endothelium-dependent 
vasodilation include increased cyclooxygenase production of vasodilating prostaglandins, 
the elevated release of endothelium derived hyperpolarizing factor, the inhibition of 
NADPH oxidase and subsequently the attenuation of superoxide production, and the 
inhibition of calcium influx into vascular smooth muscle cells (32, 38). However, given 
the significant role of NO in cardioprotection, perhaps the most important estrogen-
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mediated mechanisms in the vasculature involve the augmentation of NO production by 
the up regulation of eNOS transcription and increased eNOS phosphorylation (26, 32, 
38). Despite the clear importance of investigating alterations in vascular function with 
age in women, and the prevalence of peripheral vascular dysfunction in the lower limbs, 
to our knowledge, there has yet to be a single study examining NO-mediated vasodilation 
in the lower limbs of pre- and postmenopausal women. 
Individual levels of physical activity and fitness may also impact CVD 
progression with age. Atherosclerotic lesions tend to form at arterial bifurcations (i.e., 
branch points in the arterial tree), which are characterized by low mean blood velocity, 
high retrograde shear, and high oscillatory shear forces on the luminal surface of the 
arterial wall (22, 33, 49). This proatherogenic shear pattern is augmented with advancing 
age (33). During dynamic exercise, anterograde blood flow is profoundly increased to 
active skeletal muscle, leading to high mean blood velocity, a reduction in oscillatory 
shear, and an overall antiatherogenic blood flow profile (19, 42). Additionally, the acute 
stress placed on the vasculature during exercise increases the expression of various 
proteins that promote the production of vasodilators (13, 31, 40), increase antioxidant 
enzymes (9, 15, 18, 40), and decrease antagonist stimuli (17, 29, 48). Indeed, evidence 
exists of vascular function being augmented in old endurance trained subjects, and 
increased in previously sedentary old subjects by exercise training (4, 39). However, this 
work has been performed exclusively in the arm; therefore, although providing important 
insight into vascular aging, these studies may not reflect changes in NO bioavailability in 
the potentially more important locomotor muscles of the lower limbs, which have a 
predisposition to develop vascular disease (6, 30, 53).  
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Finally, elevated free radicals may have a deleterious effect on vascular function. 
Free radicals are molecules with one or two unpaired electrons that can oxidize other 
molecules. These oxidizing reactions can lead to decreased NO bioavailability in 
endothelial and vascular smooth muscle cells both by the direct destruction of NO, such 
as the reaction of superoxide (O2-) with NO to produce peroxynitrite (OONO-), and by 
decreasing essential cofactors of NO production, such as tetrahydrobiopterin (BH4). 
Oxidizing reactions are opposed by enzymatic (e.g., Superoxide dismutase) and non-
enzymatic (e.g., Vitamin C) antioxidants to maintain an appropriate 
prooxidant/antioxidant balance. However, when the production of free radicals outstrips 
antioxidant defenses, the result is oxidative stress, which potentially leads to vascular 
dysfunction and cellular damage. Oxidative stress has been demonstrated to increase with 
advancing age (5, 36), and contributes to impaired vasodilation in the old (5, 51). 
Increased antioxidant capacity, achieved by the infusion of ascorbic acid (Vitamin C), 
restores endothelium-dependent vasodilation in the brachial artery of old subjects, 
suggesting that acute antioxidant supplementation can limit oxidative stress and improve 
the vasodilatory response in the old (8, 43, 44). However, currently the literature specific 
to the effect of antioxidant supplementation on vascular function of the lower limbs with 
age is lacking. 
It is clear that measuring the bioavailability of NO has useful clinical 
implications. However, recently the validity of the most widely utilized method of non-
invasively assessing NO-mediated vascular function, brachial artery flow-mediated 
dilation (FMD), has been called into question in terms of both its reliability and NO 
dependence (35, 37, 47, 52). Additionally, growing evidence that limb-specific vascular 
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aging may lead to greater dysfunction in the arteries of the lower limbs suggests that 
brachial artery FMD may not be the most appropriate measure of global vascular health 
(6, 30, 50). This has meant that there is a burgeoning interest in identifying alternative, 
clinically relevant, methods with which to assess vascular function. 
PLM, an exercise model essentially devoid of increases in metabolism, and 
therefore metabolically-mediated vasodilation, results in a transient yet significant 
increase in leg blood flow (LBF) and leg vascular conductance (LVC) (12, 46). In the 
young, the hyperemic response to PLM has been documented to predominantly reflect 
NO-dependent vasodilation (11, 28, 46). Indeed, reducing NO bioavailability via nitric 
oxide synthase (NOS) inhibition (intra-arterial infusion of NG-monomethyl-L-arginine, L-
NMMA) greatly reduces the vasodilatory response to PLM in young males (11, 28, 46).  
With healthy aging, PLM-induced vasodilation is attenuated (12, 27), and this 
attenuation is due mainly to a reduction in NO bioavailability (11, 45). Interestingly, the 
influence of NO on PLM-induced vasodilation is even more evident when utilizing 
alterations in body posture. In the supine posture, vascular pressures are normalized 
across the body, but in the upright-seated posture, gravity acts to form a hydrostatic 
column in the vasculature, which differentially increases arterial and venous blood 
pressure in the legs, such that FPP is increased. In young men, this increased FPP doubles 
the vasodilatory response to PLM (12), an augmentation that is almost exclusively NO 
mediated (11). However, due to attenuated NO bioavailability, increasing FPP in old men 
has no effect on the PLM-induced vasodilation (11). Taken together, these findings 
suggest that the vasodilatory response to PLM, with and without alterations in FPP, could 
be a clinically relevant tool to assess NO-mediated vascular function, as well as for 
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determining the mechanisms responsible for the age-associated reduction in NO 
bioavailability. 
Accordingly, we examined PLM-induced vasodilation during alterations in FPP in 
young and old subjects. Specifically, the first study examined the PLM-induced 
vasodilatory response in healthy young and old female subjects. The second study 
compared the vasodilatory response to PLM in sedentary young controls and in old 
subjects across three levels of physical activity (sedentary, physically active, and 
endurance trained) to evaluate the impact that exercise has on vascular function of the 
lower limbs with age. The third study utilized oral antioxidant supplementation in young 
and old healthy sedentary subjects to assess the contribution of oxidative stress to the 
attenuated PLM-induced vasodilation with age. The overall objective of this dissertation 
was to provide insight into the mechanisms responsible for attenuated NO bioavailability 
and subsequently limited PLM-induced vasodilation in the lower limbs with age. 
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Figure 1.1 Vasodilating pathway of endothelium-derived nitric oxide. CaM, calmodulin; 
Ca2+, calcium; CaM K II, calmodulin kinase II; AMPK, 5’ adenosine monophosphate-
activated protein kinase; PKA, protein kinase A; eNOS, endothelial nitric oxide synthase; 
NADPH, nicotinamide adenine dinucleotide phosphate hydrogen; NADP+, nicotinamide 
adenine dinucleotide phosphate; BH4, tetrahydrobiopterin; NO, nitric oxide; GC, 
guanylyl cyclase; GTP, guanosine 5’ triphosphate; cGMP, cyclic guanosine 
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Groot HJ, Rossman MJ, Trinity JD, Layec G, Ives SJ, Richardson
RS. Passive leg movement-induced vasodilation in women: the impact of
age. Am J Physiol Heart Circ Physiol 309: H995–H1002, 2015. First
published July 17, 2015; doi:10.1152/ajpheart.00422.2015.—Passive leg
movement (PLM), an assessment of predominantly nitric oxide-
dependent vasodilation, is decreased with age and cannot be aug-
mented by posture-induced increases in femoral perfusion pressure in
older men. However, this novel method of assessing vascular function
has yet to be used to evaluate alterations in nitric oxide-dependent
vasodilation with age in females. PLM was performed in 10 young
(20 ! 1 yr) and 10 old (73 ! 2 yr) women in both the supine and
upright-seated postures, whereas central and peripheral hemodynamic
measurements were acquired second by second using noninvasive
techniques (finger photoplethysmography and Doppler ultrasound,
respectively). The heart rate response to PLM was attenuated in the
old compared with the young in both the supine (young, 10 ! 1; and
old, 5 ! 1 beats/min; P " 0.05) and upright-seated posture (young,
10 ! 2; and old, 5 ! 1 beats/min; P " 0.05), leading to a blunted
cardiac output response in the old in the upright-seated posture
(young, 1.0 ! 0.2; and old, 0.3 ! 0.1 l/min; P " 0.05). The
PLM-induced peak change in leg vascular conductance was lower in
the old compared with the young in both postures (young supine,
5.7 ! 0.5; old supine, 2.6 ! 0.3; young upright, 9.2 ! 0.7; and old
upright, 2.2 ! 0.4 ml·min#1·mmHg#1; P " 0.05) and was signifi-
cantly augmented by the upright-seated posture in the young only,
revealing a vasodilatory reserve capacity in the young (3.5 ! 0.6
ml·min#1·mmHg#1, P" 0.05) that was absent in the old (#0.5! 0.3
ml·min#1·mmHg#1, P $ 0.18). These data support previous literature
demonstrating attenuated PLM-induced vasodilation with age and extend
these findings to include the female population, thus bolstering the utility
of PLM as a novel assessment of vascular function across the life span in
humans.
passive leg movement; vascular function; posture; endothelium
NEW & NOTEWORTHY
Passive leg movement (PLM) is a novel method of assessing
predominantly nitric oxide mediated vascular function. PLM-
induced vasodilation is attenuated with age in men; however,
PLM has never before been used in the female population. Our
data demonstrate that aging impairs PLM-induced vasodila-
tion in women, thus expanding the utility of the PLM model.
RECENTLY, PASSIVE LEG MOVEMENT (PLM), a novel method for
assessing vascular function, has been gaining recognition. In
the supine posture, PLM initiates a vasodilatory response in
young men that has been documented to be attenuated in old
men (28, 39), is predominantly nitric oxide (NO) mediated, and
therefore likely reflects endothelium-dependent vascular func-
tion (28, 39). Interestingly, when femoral perfusion pressure
(FPP) is increased by moving from the supine to the upright-
seated posture, young men exhibit an NO-mediated vasodila-
tory reserve capacity, whereas old men, due to diminished NO
bioavailability, do not (10, 11). Likewise, the initial vasodila-
tory response to PLM (%9 s) differs between young and old
men, with the old demonstrating a slower onset (10, 11, 38).
Due to the powerful antiatherogenic properties of NO (18, 34),
and the importance of intact vascular function in cardiovascu-
lar disease (CVD) prevention, an assessment such as the
response to PLM, which has the potential to be used across the
life span, may be of great clinical importance. However, this
novel method of assessing vascular function has yet to be used
to evaluate alterations in endothelium-dependent vasodilation
with age in females.
Premenopausal women appear to have a reduced risk of
CVD compared with both men and postmenopausal women
(21). This has led to the belief that young women possess an
inherent cardioprotection, which may be related to estrogen.
Estrogen, which declines postmenopause, is recognized to have
powerful effects on the vasculature. As a steroid hormone,
estrogen is able to diffuse easily across endothelial and vascu-
lar smooth muscle cell membranes, resulting in vascular-
specific genomic modifications, such as increased endothelial
NO synthase (eNOS) transcription and ultimately eNOS pro-
tein expression (29) and nongenomic effects, such as eNOS
activation and NADPH oxidase inhibition (29). Thus post-
menopausal women would be expected to have decreased
NO-mediated vascular function compared with young women,
and, indeed, this has been the conclusion of studies using the
brachial artery flow-mediated dilation (FMD) technique (4,
13). However, due to procedural complexities that have limited
the clinical usefulness of FMD and recent questions regarding
the contribution of NO to FMD (31, 45), there is a growing
need to develop a clinically relevant tool that can be used to
track the changes in vascular function of women across the life
span.
Consequently, the purpose of this investigation was to assess
vascular function in young and old women using the novel
PLM test. Specifically, we hypothesized that 1) old women
would exhibit an attenuated PLM-induced vasodilation com-
pared with young women, 2) increasing FPP by assuming an
upright-seated posture would augment the vasodilatory re-
sponse in young women only, such that 3) the vasodilatory
reserve capacity would be greater in the young women than in
the old women and 4) increased FPP would augment the rapid
vasodilation in the young women, with no change in the old
women. If proven to be correct, such findings would support
the potential clinical relevance of the PLM test for assessing
vascular function in women across the life span.
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Twenty healthy women (10 young and 10 old) participated in this
research study. Subjects were included based on a lack of overt
cardiovascular or metabolic disease and aged 18–25 yr for the young
and !65 yr for the old. All procedures were approved by the
Institutional Review Boards of the University of Utah and the Salt
Lake City Veterans Affairs Medical Center, and written informed
consent was obtained from each participant before inclusion in the
study. The study conformed to the standards set by the Declaration of
Helsinki.
Experimental Protocol
Each subject reported to the laboratory for both a familiarization
and experimental trial. Upon arrival for the familiarization trial,
anthropometric measurements were performed, followed by instru-
mentation and PLM, both to acquaint participants with the experi-
mental procedure and to ensure their ability to remain relaxed during
a PLM protocol.
Subjects arrived on the experimental day fasted and having re-
frained from caffeine for 12 h prior, and exercise for 24 h before the
initiation of data collection. To control for variations in circulating
hormones, young females were included only if they were not taking
pharmaceutical contraceptives and were then studied within the first 7
days (follicular phase) of the menstrual cycle. The old women were
postmenopausal and not on hormone replacement therapy. Blood was
collected from the antecubital vein to assess blood lipids, fasting
glucose, C-reactive protein (CRP), ferric-reducing ability of plasma
(FRAP), protein carbonyl, and hemoglobin and to perform a complete
blood cell count. Subjects were then assigned to either the supine or
upright-seated posture using a counterbalanced design. After instru-
mentation, participants rested for at least 20 min in the assigned
posture before the start of data collection.
Hemodynamic measurements were collected during 1 min of base-
line with the leg held at a 180° knee joint angle, followed by 2 min of
passive knee flexion-extension through a 90° range of motion (180-
90°) at 1 Hz. Throughout the protocol, the contralateral leg remained
supported and motionless with the knee joint extended (180°). PLM
was achieved by a member of the research team with real-time
feedback provided by a position sensor and digital display to ensure
full range of motion. A metronome, initiated before the start of
baseline data collection, was used to maintain cadence. Before the
start and throughout the protocol participants were encouraged to
remain passive and to resist the urge to help or hinder the passive
movement. To avoid the startle reflex, participants were made aware
that the PLM would begin in "1 min but were not told exactly when
the movement would begin to reduce the chance of an anticipatory
response (42). The protocol was repeated in the opposing body
posture (supine or upright seated) after a rest period of at least 20 min
in the new posture.
Baseline for all variables was determined using the average of the
data for the 60 s before the initiation of PLM. Data collected during
the first minute of PLM were analyzed second by second and
smoothed using a 3-s rolling average before final data analysis, with
12 s-averages used for the second minute of movement.
Measurements
Central hemodynamics. Heart rate (HR) was determined using an
electrocardiogram (ECG), and mean arterial pressure (MAP) was
determined by finger photoplethysmography with a Finometer (Fi-
napres Medical Systems, Amsterdam, The Netherlands) positioned at
heart level. Stroke volume (SV) was calculated using the Modelflow
method (Beatscope, version 1.1; Finapres Medical Systems), with
cardiac output (CO) calculated as the product of SV and HR.
Throughout each protocol, ECG, SV, CO, and MAP signals under-
went analog-to-digital conversion and were simultaneously acquired
(200 Hz) using commercially available data acquisition software
(AcqKnowledge, Biopac Systems, Goleta, CA).
Peripheral hemodynamics. Measurements of blood velocity in the
common femoral artery (CFA) and vessel diameter were performed in
the passively moved leg distal to the inguinal ligament and proximal
to the bifurcation of the superficial and deep femoral artery using a
Logic 7 ultrasound system (General Electric Medical Systems, Mil-
waukee, WI). The Logic 7 was equipped with a linear array transducer
operating at an imaging frequency of 14 MHz. CFA diameter was
determined at a perpendicular angle along the central axis of the
scanned area, and blood velocity was measured using the same
transducer with a frequency of 5 MHz. All blood velocity measure-
ments were obtained with the probe appropriately positioned to
maintain an insonation angle of 60° or less. The sample volume was
maximized according to vessel size and was centered within the vessel
based on real-time ultrasound visualization. With the use of CFA
diameter and mean velocity (Vmean; angle corrected and intensity
weighted) leg blood flow (LBF) was automatically calculated by
commercially available software (Logic 7) as Vmean#(vessel diameter/
2)2 $ 60, where blood flow is in milliliters per minute. Leg vascular
conductance (LVC) was calculated as LBF divided by MAP. The peak
changes in LBF and LVC (%LBFpeak and %LVCpeak, respectively)
were calculated as peak minus baseline, cumulative area under the
curve (LBFAUC and LVCAUC) was calculated as !{yi[x(i&1) ' xi] &
(1/2)[y(i&1) ' yi][x(i&1) ' xi]}, and vasodilatory reserve capacity was
calculated as the upright-seated %LVCpeak minus the supine
%LVCpeak.
Blood assays. Glucose, lipids, and complete blood cell count were
determined using standard clinical techniques. Plasma and serum
samples were stored at '80° until analysis. The FRAP assay was
performed to assess total antioxidant capacity, using the method
described by Benzie and Strain (3), whereas oxidative stress was
assessed by measuring protein carbonyl levels (Northwest Life Sci-
ence Specialties, Vancouver, WA). Systemic inflammation was as-
sessed by measuring CRP levels (R&D Systems, Minneapolis, MN).
All assays were performed in duplicate.
Knee joint angle. During each protocol, knee joint angle of the
passively moved leg was continuously recorded using a Vishay
Spectrol 360 degree Smart Position Sensor (Vishay Intertechnology,
Malvern, PA) mounted on a BREG X2K knee brace (BREG, Vista,
CA) worn by the participants.
Anthropometrics. Body mass and height were recorded and used to
calculate body mass index (BMI) as BMI ( body mass $ height2,
where body mass is measured in kilograms and height is measured in
meters. Thigh volume of the passively moved leg was calculated, as
previously described (19), using three measurements of thigh circum-
ference (proximal, middle, and distal), thigh length, and skinfold
measurements.
Physical activity level. Physical activity level (PAL) was assessed
using both a subjective PAL recall questionnaire and objective accel-
erometer data. The PAL questionnaire included items regarding the
average type, frequency, intensity, and duration of physical activity in
any given week. After receiving standardized operating instructions,
subjects wore an accelerometer (GT1M; Actigraph, Pensacola, FL)
for a minimum of a continuous 7 days, with adherence automatically
assessed by the device. Average total daily physical activity was
expressed as both average steps per day, and average total acceler-
ometer as counts per minute. The latter assessment was separated into
sedentary, low-, moderate-, high-, and very high-intensity catego-
ries using device-specific software (Actilife, Pensacola, FL). Pre-
vious research has documented the validity and reliability of the
Actigraph GT1M in terms of the estimation of daily physical
activity with both steps per day and accelerometer counts per
minute (1, 43). Classification of the subjects’ level of physical
activity, as determined by steps per day, was based on a validated
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scale (sedentary, !5,000; low active, 5,000 –7,499; somewhat
active, 7,500 –9,999; active, 10,000 –12,499; and highly active,
!12,500 steps/day) (33, 40).
Statistical Analysis
Two-way, repeated-measures ANOVA were used to determine
significant differences in baseline and the absolute change from
baseline to peak for HR, SV, CO, MAP, LBF and LVC, as well as
AUC for LBF and LVC. Student’s t-tests were used to compare
subject characteristics. Pearson’s correlations were employed to as-
sess the strength of relationships between variables. Significance was
set at an "-level of 0.05, and data are presented as means # SE.
RESULTS
Subjects
In addition to an average age difference of over 50 yr, the old
women had significantly greater body mass ($19%), BMI
($18%), total cholesterol ($30%), protein carbonyl ($52%),
CRP ($393%), and larger CFA diameter ($13%) (Table 1). The
groups exhibited similar total daily physical activity, as assessed
by both questionnaire and accelerometry, and all subjects were
categorized within the sedentary to low physical activity ranges
based on the step-determined scale (Table 1) (33, 40).
Central Hemodynamics
Resting and peak changes in central hemodynamics are
displayed in table 2. At rest there was no difference in SV, HR,
or CO between groups in either body posture. While all
subjects were normotensive (!140/90 mmHg), resting MAP
was significantly higher in the old compared with the young
women in both body postures (P ! 0.05). In the young, the
upright-seated posture elicited a significant decrease in SV
(P ! 0.05) and an increase in HR (P ! 0.05) that maintained
CO, whereas the same posture alterations had no effect on
central hemodynamics at rest in the old.
Both groups demonstrated significant increases in SV, HR,
and CO and decreases in MAP (P ! 0.05) as a consequence of
PLM. However, the %HRpeak was significantly lower in the old
compared with the young in both body postures, and the
%SVpeak was greater in the young with the upright-seated
posture, while tending to be lower in the old with this posture
(P & 0.19), resulting in an attenuated %COpeak in the old
women while in the upright-seated posture (P ! 0.01). De-
creases in MAP (%MAPpeak) during PLM were similar be-
tween groups and postures.
Leg Blood Flow and Leg Vascular Conductance
Resting, peak change, and AUC data for peripheral hemo-
dynamics are displayed in Table 2. Resting LBF and LVC were
Table 1. Subject characteristics
Young Old
n 10 10
Age, yr 20 # 1 73 # 2#
Height, cm 162 # 2 163 # 1
Weight, kg 58 # 2 69 # 3#
Body mass index, kg/m2 22 # 1 26 # 1#
Thigh volume, dl 42 # 3 44 # 3
CFA diameter, cm 0.71 # 0.01 0.80 # 0.02#
Glucose, mg/dl 71 # 2 75 # 2
Cholesterol, mg/dl 171 # 12 221 # 11#
Triglycerides, mg/dl 80 # 9 126 # 18
HDL, mg/dl 57 # 3 62 # 2
LDL, mg/dl 99 # 10 127 # 9
Hemoglobin, g/dl 14.1 # 0.3 14.3 # 0.1
White blood cell, k/'l 5.4 # 0.4 5.4 # 0.5
Neutrophil, k/'l 2.8 # 0.3 3.0 # 0.3
Lymphocyte, k/'l 2.0 # 0.2 1.8 # 0.1
Monocyte, k/'l 0.46 # 0.02 0.42 # 0.03
FRAP, mM/ml 0.90 # 0.01 0.88 # 0.04
Protein carbonyls, (m/mg 0.089 # 0.004 0.135 # 0.010#
C-reactive protein, (g/ml 317 # 59 1,563 # 249#
Activity counts/min 156 # 21 119 # 15
Steps/day 6,734 # 797 5,012 # 563
Values are means # SE; n, number of subjects. CFA, common femoral
artery; FRAP, ferric-reducing ability of plasmaprotein. #P ! 0.05, signifi-
cantly different from young women.
Table 2. Central and peripheral hemodynamics
Supine Upright Seated
Young Old Young Old
Rest
MAP, mmHg 86 # 2 104 # 7# 81 # 3 106 # 6#
CO, l/min 4.9 # 0.3 4.7 # 0.5 4.9 # 0.2 4.1 # 0.4
SV, ml/beat 75 # 4 80 # 8 69 # 2* 73 # 8
HR, beats/min 66 # 4 63 # 1 71 # 4* 64 # 2
LBF, ml/min 351 # 44 284 # 29 350 # 44 229 # 21#*
LVC, ml ! min)1 ! mmHg)1 4.0 # 0.5 2.9 # 0.4 4.3 # 0.5 2.2 # 0.2#
Passive leg movement
%MAPpeak, mmHg )11 # 1 )14 # 2 )12 # 1 )17 # 2
%COpeak, l/min 0.7 # 0.1 1.2 # 0.5 1.0 # 0.2 0.3 # 0.1#
%SVpeak, ml/beat 4 # 1 14 # 6 10 # 2* 6 # 1
%HRpeak, beats/min 10 # 1 5 # 1# 10 # 2 5 # 1#
%LBFpeak, ml/min 490 # 34 250 # 33# 713 # 59* 224 # 40#
LBFAUC, ml/min 200 # 23 79 # 22# 284 # 45* 67 # 17#
%LVCpeak, ml ! min)1 ! mmHg)1 5.7 # 0.5 2.6 # 0.3# 9.2 # 0.7* 2.2 # 0.4#
LVCAUC, ml ! min)1 ! mmHg)1 2.3 # 0.3 0.8 # 0.2# 3.3 # 0.5* 0.6 # 0.2#
Values are means # SE; n & 10 old and 10 young women. MAP, mean arterial pressure; CO, cardiac output; SV, stroke volume; HR, heart rate; LBF, leg
blood flow; LVC, leg vascular conductance; %peak, peak change from baseline; AUC, area under the curve. *P! 0.05, significantly different from supine posture;
#P ! 0.05, significantly different from young women.
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not different between groups in the supine posture. With the
upright-seated posture, resting LBF was reduced in the old,
such that both LBF and LVC were significantly lower in old
compared with young women.
PLM in the supine and upright-seated postures resulted in a
significant hyperemic response in both the young and old
women (P ! 0.05; Table 2, Figs. 1 and 2). In the supine
posture, "LBFpeak and LBFAUC were attenuated in the old
compared with the young women (49 and 60%, respectively;
Fig. 1, B and C), resulting in a similarly attenuated "LVCpeak
and LVCAUC (54 and 66%, respectively; Fig. 2, B and C) in the
old. The upright-seated posture significantly increased the LBF
("LBFpeak # 46%, and LBFAUC # 42%; Fig. 1, B and C) and
LVC ("LVCpeak # 61%, and LVCAUC # 43%; Fig. 2, B and
C) response to PLM in the young, with no effect of posture in
the old. This posture-induced increase in "LVCpeak in response
to PLM in the young women revealed a significant vasodilatory
reserve capacity (3.5 $ 0.6 ml·min%1·mmHg%1; P ! 0.001)
that was absent in the old (%0.5 $ 0.3 ml·min%1·mmHg%1;
P # 0.18) women (Fig. 3).
In terms of total antioxidant capacity, oxidative stress, and
inflammation, neither FRAP nor PC was significantly related to
either "LVCpeak or LVCAUC. CRP displayed a significant
negative relationship to "LVCpeak in the supine and upright-
seated posture (r # 0.56, P ! 0.01; and r # 0.70, P ! 0.001,
respectively), as well as with the vasodilatory reserve capacity
(r # 0.65, P ! 0.01). Similarly, CRP was negatively related to
both supine and upright-seated LVCAUC (r # 0.56, P ! 0.05;
and r # 0.65, P ! 0.01, respectively).
The immediate vasodilatory response (slopes of increas-
ing LVC over time, for the first 9 s) to PLM was signifi-
cantly reduced with age in both the supine (old, 0.15 $ 0.04;
and young: 0.55 $ 0.04; P ! 0.001) and the upright-seated
(old, 0.16 $ 0.06; and young, 0.93 $ 0.09; P ! 0.001)
postures and was significantly elevated in the upright-seated
posture, compared with supine, in the young only (P !
0.001; Fig. 4).
DISCUSSION
The purpose of this investigation was to increase the gener-
alizability of the PLM model by extending the previous liter-
ature to include the female population. Similar to findings in
men, older women demonstrated an attenuated vasodilatory
response to PLM in the supine posture compared with the
young. The upright-seated posture, which significantly aug-
mented the PLM-induced vasodilation in young women, had
no effect on the vasodilatory response in the old. Similarly, in
the old, the rapid vasodilatory (first 9 s) response to PLM in the
supine posture was attenuated compared with the young
women, and unlike in the young where the response was
accelerated, the rapid vasodilatory response in the old
women remained unchanged with increased FPP, thus re-
sulting in a greater age difference in the upright-seated
posture. Finally, the augmented PLM-induced "LVCpeak
due to the upright-seated posture revealed a significant
vasodilatory reserve capacity in young women that was
absent in the old. These findings demonstrate that vascular
function, assessed by the PLM model, declines with age in
women. This expands the use of PLM to a wider population
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Fig. 1. Passive leg movement (PLM)-induced changes in leg blood flow
(LBF) with age in women. A: second-by-second tracing of LBF (ml/min) at
baseline (BL) and throughout 2 min of PLM. B: peak change in LBF from
BL ("LBFpeak, ml/min); C: LBF area under the curve (AUC) for the first 60
s of PLM (LBFAUC, ml/min). Young, n # 10; old, n # 10. BL indicates the
average of the 60 s just before initiation of PLM. Dashed line at 0 s
indicates the start of 2 min of PLM. *P ! 0.05, significantly different from
supine posture; #P ! 0.05; significantly different from young women.
Values are means $ SE.
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and bolsters the utility of PLM as a vascular function
assessment across the human life span.
Age and Supine PLM-Induced Vasodilation in Women
PLM is an experimental model whereby changes in quadri-
ceps and hamstring muscle length, without increases in metab-
olism, cause a significant increase in LBF and LVC. This
PLM-induced hyperemia has previously been reported in both
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Fig. 2. PLM-induced changes in leg vascular conductance (LVC) with age in
women. A: second-by-second tracing of LVC (ml·min!1·mmHg!1) at baseline
and throughout 2 min of PLM. B: peak change in LVC from BL ("LVCpeak,
ml·min!1·mmHg!1). C: LVC AUC for the first 60 s of PLM (LVCAUC,
ml·min!1·mmHg!1). Young, n # 10; old, n # 10. BL indicates the average of
the 60 s just before initiation of PLM. Dashed line at 0 s indicates the start of
2 min of PLM. *P $ 0.05, significantly different from supine posture; #P $
































Fig. 3. PLM-induced vasodilatory reserve capacity with age in women. The
difference in the PLM-induced "LVCpeak (ml·min!1·mmHg!1) between the
supine and upright-seated posture (vasodilatory reserve capacity). Young, n #
10; old, n # 10. #P $ 0.05, significantly different from young women. Values
are means % SE.
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Fig. 4. PLM-induced rapid vasodilation with age in women. The rate of
increase in the LVC (ml·min!1·mmHg!1) over time was determined for the
first 9 s of PLM. Young, n# 10; old, n# 10. *P$ 0.05, significantly different
from supine posture; #P $ 0.05, significantly different from young women.
Values are means % SE.
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young and old men; however, the magnitude of the vasodila-
tory response to PLM is significantly attenuated with age (11,
23). Recent investigations into the mechanisms responsible for
the PLM response conclude that PLM-induced vasodilation is
predominantly NO mediated in young men, as evidenced by an
!80–90% reduction in the hyperemic response during intra-
arterial infusion of the NO synthase (NOS) inhibitor NG-
monomethyl-L-argenine (10, 28, 39). Furthermore, by once
again using NOS inhibition, both Trinity et al. (38) and Groot
et al. (10) reported that the attenuated PLM-induced vasodila-
tion described in older men was a consequence of reduced NO
bioavailability with age. However, before this investigation,
the PLM model had not been used to examine alterations in
vascular function with age in women.
Results from the current investigation, which are strikingly
similar to those previously reported in young and old men (11,
23), reveal a significant age-associated reduction in the PLM-
induced "LBFpeak and "LVCpeak in the supine posture
(!50%) in old women compared with young, likely because of
decreased NO bioavailability (Table 2, and Figs. 1B and 2B).
Of note, when individual responses were examined, the PLM-
induced hyperemia was lower in all 10 of the older women
compared with all, but one, of the young subjects. It should be
noted that the old women had less of a HR response to PLM
than the young; however, given that the PLM-induced
"MAPpeak was similar between young and old, it is unlikely
that this central hemodynamic difference contributed to the
peripheral hemodynamic findings. This supposition is sup-
ported by the LVC data, which take MAP into account (Fig. 2).
Additionally, the rapid vasodilatory response (slope of the
increasing LVC over time for the first 9 s) to PLM, previously
determined to be NO-independent in men in the supine posture
(10, 38), was also significantly attenuated with age in women
(! 70%; Fig. 4). At the initiation of PLM, mechanical defor-
mation of the vascular beds of the thigh may release vasodi-
lators that act independently of the NO pathway (6, 17, 24).
However, despite differences in this initial non-NO-dependent
portion of the PLM response, subsequent mechanotransduction
of wall shear forces likely contribute to the vasodilatory cas-
cade making NO the dominant vasodilator for the remainder of
PLM (14, 25, 30, 35).
Age and Upright-Seated PLM-Induced Vasodilation in
Women
The upright-seated posture, which similarly increases FPP in
young and old men (11), significantly augmented the PLM
response in the young women, while having no effect on the
old (Table 2, and Figs. 1 and 2). Of note, examination of the
individual responses revealed that the PLM-induced hyperemia
was augmented by the upright-seated posture in all ten young
women, whereas the response in the old women was mixed.
This posture-induced increase in vasodilation during PLM in
the young enhanced the rapid vasodilation (Fig. 4) and re-
vealed a vasodilatory reserve capacity that was absent in the
old (Fig. 3).
Groot et al. (10) demonstrated that the increased rapid
hyperemia with the upright-seated posture in young men could
be attenuated to similar levels as the supine posture with NOS
inhibition, but this rapid hyperemia was unaffected by posture
in old men. This indicates that the onset of NO-mediated
vasodilation during PLM is accelerated by increased FPP in the
young, but not the old, and lends additional utility to the PLM
model as an assessment of NO-mediated vasodilation. Simi-
larly, whereas the upright-seated posture significantly aug-
mented the PLM-induced rapid vasodilation in young women,
the same postural alteration had no effect on the old (Table 2,
and Figs. 1 and 2). In light of previous evidence that the
increase in rapid vasodilation at the onset of PLM is reliant on
NO, it can be inferred that this lack of an effect of the
upright-seated posture on the rapid vasodilation in the old
women is likely due to reduced NO bioavailability with age.
The ability for the "LVCpeak to increase when moving from
the supine to upright-seated posture has been recognized to
represent a vasodilatory reserve capacity (11). The upright-
seated posture elicits a similar (!7 mmHg) increase in FPP in
both young and old men, as measured directly in the CFA and
vein (11). This augmented driving force of blood across the
vascular beds of the thigh has the potential to increase endo-
thelial shear forces at the onset of PLM, thereby resulting in a
greater NO-mediated vasodilation. This was indeed the case in
young men whose "LVCpeak nearly doubled in the upright-
seated posture, revealing a vasodilatory reserve capacity that
was nearly entirely due to NO (10). In contrast, because of
reduced NO bioavailability with age, similar increases in FPP
in old men did not augment the "LVCpeak in the upright-seated
posture, thus a vasodilatory reserve capacity was absent in the
old (10). In support of these previous findings, the young
women displayed a significant vasodilatory reserve capacity,
whereas the old women, who already possessed an attenuated
PLM response compared with the young in the supine posture,
failed to increase their "LVCpeak in the upright-seated posture
and therefore lacked any vasodilatory reserve capacity (Fig. 3).
Given that the vasodilatory reserve is an NO-mediated phe-
nomena, its absence in older women provides additional evi-
dence that NO bioavailability, as measured by PLM, is de-
creased with age.
Age and NO Bioavailability in Women
While it is clear that PLM-induced vasodilation is attenuated
in older humans, the mechanisms leading to this age-associated
decrease in NO bioavailability remain unclear. However, pre-
vious reports implicate an age-associated increase in oxidative
stress and, specifically in women, the postmenopausal fall in
circulating estrogen as likely causes of impaired vascular
function and NO bioavailability with age.
Oxidative stress is the result of free radicals, molecules with
unpaired electrons that lead to oxidizing reactions, which
interfere with cellular processes resulting in damage, dysfunc-
tion, and/or apoptosis. Many of these free radicals are found in
the vasculature and can interfere with NO signaling, thus
diminishing NO bioavailability (5, 44). Indeed, markers of free
radical production are elevated in old subjects in both endo-
thelial cells and circulating plasma (8, 12, 41, 44) and are
associated with decreased vascular function (8, 44). Interven-
tions aimed at acutely decreasing oxidative stress, such as the
infusion of the antioxidant ascorbic acid, result in improved
vascular function and NO bioavailability in old subjects (9, 36,
37). In the present investigation, the older women, while not
exhibiting an attenuated total antioxidant capacity, as assessed
by FRAP, did have significantly elevated levels of inflamma-
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tion and oxidative stress (Table 1). Additionally, although
FRAP and protein carbonyls were unrelated to the PLM re-
sponse, CRP was significantly related to measures of PLM-
induced vasodilation (r ! 0.56–0.70), suggesting that inflam-
mation may play a role in the attenuated PLM response with
age in women. However, further investigations into the possi-
ble effects of oxidative stress on PLM-induced vasodilation
with age are necessary.
Estrogen has powerful effects on NO production, and this
phenomenon is likely, at least in part, responsible for the
observation that premenopausal women have decreased CVD
risk compared with men and postmenopausal women. Estrogen
can cause genomic modifications, such as increased transcrip-
tion and ultimately the expression of eNOS protein (26, 29), As
well as nongenomic effects, such as increased eNOS activation
(16, 20, 26, 29). Furthermore, estrogen provides additional
antioxidant effects by inhibiting NADPH oxidase and aug-
menting superoxide dismutase, thereby decreasing oxidative
stress in the vasculature (26, 29). By these mechanisms, estro-
gen can decrease free radical production and NO scavenging
and improve eNOS coupling and NO synthesis, resulting in
greater NO bioavailability. Therefore, drastic reductions in
estrogen after menopause likely contribute to decreased NO-
mediated vasodilation and impaired vascular function in older
women. Support for this supposition can be found by a direct
comparison of the current investigation to previously published
PLM results in men which suggest that women may have a
greater age related impairment in vascular function (11, 23).
Indeed, the magnitude of attenuation in the PLM response with
age in women is 10–20% greater than that reported in men and
may be potentially due to the postmenopausal fall in estrogen.
Furthermore, previous investigations examining endothelium-de-
pendent vasodilation with age in women have revealed reduced
vasodilation in postmenopausal women compared with young
women (4, 13) and in ovariectomized rats compared with intact
animals (20, 27). These reductions in vascular function can be
rescued with hormone replacement therapy (7, 15, 20, 27, 32). A
direct assessment of the potential link between estrogen levels and
PLM-induced hyperemia warrants further investigation.
Experimental Considerations
Because of the minimally invasive nature of this study, the
direct measurement of femoral arterial, venous, and the subse-
quent calculation of actual perfusion pressure was not per-
formed. Therefore, while we cannot rule out the possibility of
differential FPP responses to the upright-seated posture in
young and old women, a similar study performed in men
reported identical posture-induced increases in FPP between
the young and old subjects (11). Furthermore, while older
women display some differences in orthostatic coping strate-
gies compared with men, the responsiveness of peripheral
resistance vessels appears to be similar (2), suggesting that FPP
responses to the upright-seated posture are likely comparable
to those previously reported in young and old men. Addition-
ally, because infusion of a NOS inhibitor was not performed,
we cannot rule out the possibility that the mechanisms for the
PLM-induced vasodilation may differ between men and
women. However, Mannacio et al. (22) reported that compared
with young controls and age-matched men, older women
displayed attenuated eNOS mRNA and a reduction in internal
mammary artery relaxation in response to acetylcholine. This
would suggest that attenuated NO bioavailability with age not
only is an important factor in the impaired vascular function
observed in older women but may play an even greater role than
that observed in older men. However, future investigations into
the direct role of NO in the PLM-induced vasodilation in women
are needed. Additionally, as with any study focused on aging,
there is often some difficulty in discerning age-related changes,
such as increases in BMI and total cholesterol, from aging, per se,
and that is also the case in this investigation. Finally, the relatively
small sample size may have limited our ability to detect changes
in certain variables (e.g., triglycerides); therefore, future studies
using PLM may benefit from a larger cohort.
Conclusion
The results of the current investigation support previous find-
ings that PLM-induced vasodilation is attenuated with age and
extend these observations to include women. Additionally, in-
creasing FPP by moving from the supine to the upright-seated
posture, which magnifies the role of NO in both the rapid and
overall vasodilatory response, revealed a vasodilatory reserve
capacity in young, but not old women. These findings imply
reduced NO bioavailability with age in women and add additional
support to the utility of the PLM model as an assessment of
NO-mediated vascular function across the human life span.
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CHAPTER 3 
THE EFFECT OF PHYSICAL ACTIVITY AND FITNESS ON 
PASSIVE LEG MOVEMENT-INDUCED 
VASODILATION WITH AGE 
Abstract 
Due to reduced nitric oxide (NO) bioavailability with age, passive leg movement 
(PLM)-induced vasodilation is attenuated in older sedentary subjects and, unlike the 
young, cannot be augmented by posture-induced elevations in femoral perfusion pressure. 
However, whether vascular function assessed with PLM is improved in older individuals 
with greater physical activity and fitness is unknown. Thus, PLM was performed on four 
subject groups (young sedentary (Y, 23 ± 1 yrs, n = 12); old sedentary (OS, 73 ± 2 yrs, n 
= 12); old active (OA, 71 ± 2 yrs, n = 10); old endurance trained (OT, 72 ± 1 yrs, n = 10)) 
in the supine and upright-seated posture. Hemodynamics were measured utilizing 
ultrasound Doppler and finger photoplethysmography. In the supine posture, PLM-
induced peak change in leg vascular conductance (ΔLVCpeak) was significantly attenuated 
in the OS compared to the young (OS: 4.9 ± 0.5, Y: 6.9 ± 0.7 ml/min/mmHg), but was 
not different from the young in the OA and OT (OA: 5.9 ± 1.0, OT: 5.4 ± 0.4 
ml/min/mmHg). The upright-seated posture significantly augmented ΔLVCpeak in all but 
the OS (OS: 4.9 ± 0.5, Y: 11.8 ± 1.3, OA: 7.3 ± 0.8, OT: 8.1 ± 0.8 ml/min/mmHg), 
revealing a significant vasodilatory reserve capacity in the other groups (Y: 4.92 ± 1.18, 
OA: 1.37 ± 0.55, OT: 2.76 ± 0.95 ml/min/mmHg). As PLM reflects predominantly NO-
mediated vasodilation, these findings suggest that augmenting physical activity and 
fitness can protect NO bioavailability, attenuating the deleterious effects of advancing 
age on vascular function. 
Introduction 
An increased risk of cardiovascular disease (CVD) is a hallmark of advancing 
age. Attenuated vascular function, prior to overt signs of CVD, is an independent 
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predictor of future CVD risk (21, 38) and is likely a consequence of diminished 
endothelium-mediated vasodilation. Indeed, in sedentary older humans, endothelium-
dependent vascular function is attenuated compared to young controls, whether assessed 
by the PLM technique (15, 16, 24, 44), intra-arterial infusion of the vasodilator 
acetylcholine (ACh) (2, 7, 27, 41), or brachial artery flow-mediated dilation (FMD) (4, 6, 
9, 28). Specifically, it appears that the endothelium-derived vasodilator NO, which 
possesses antiatherogenic properties and is therefore an important factor in human aging 
(19, 23, 25, 32), is reduced in sedentary older subjects. However, whether this reduction 
in NO-dependent vascular function is the result of primary aging, or a secondary effect of 
reduced physical activity and fitness in the old is still unclear. 
Endurance exercise-training creates an antiatherogenic arterial blood flow profile 
characterized by predominantly anterograde blood flow and low oscillatory shear rate 
(18, 20, 39, 42, 49). This beneficial flow pattern acutely increases endothelial NO 
synthase (eNOS) phosphorylation (12, 17), and chronically increases eNOS protein 
expression (17, 29), likely leading to greater NO bioavailability. However, while the 
current literature demonstrates a positive effect of increasing physical activity and fitness 
in terms of maintaining NO bioavailability with advancing age (7, 9, 27, 37), these 
conclusions are based exclusively on measurements made in the arm. Therefore, although 
providing important insight into vascular aging, these studies may not reflect changes in 
NO bioavailability in the potentially more important locomotor muscles of the lower 
limbs, which have a predisposition to develop vascular disease (8, 27, 54).  
The vasodilatory response to PLM, a novel assessment of vascular function 
performed in the lower limb, has been documented to be predominantly (~80%) NO-
26
mediated in the young (26, 46), while in the old, who possess a significantly attenuated 
PLM-induced vasodilation (16, 24), NO seems to play little to no role (15, 44). 
Moreover, the vasodilatory reserve capacity (ΔLVCpeak from supine to upright-seated) 
has been demonstrated to further characterize the NO-mediated portion of the PLM 
response, and again reveals a clear attenuation with age (15). These findings, in addition 
to recent questions about the validity of brachial artery FMD as a measure of NO-
bioavailability (35, 47, 54), evidence that the lower limbs of humans age in a different 
manner than the upper limbs (8, 27, 52), and the invasiveness of intra-arterial drug 
infusions, suggest that the PLM model may be a more appropriate test of vascular 
function. However, while the validity of the PLM model to detect reductions in NO 
bioavailability and vascular function with age is clear, the effect of varying activity and 
fitness levels in older subjects on PLM-induced vasodilation is unknown. 
Therefore, the purpose of this investigation was to determine the effect of 
increasing levels of physical activity and fitness in older individuals on PLM-induced 
vasodilation in the supine and upright-seated posture in young sedentary, old sedentary, 
old active, and old endurance exercise-trained subjects. We hypothesized that 1) vascular 
function would be attenuated in the old sedentary compared to the young sedentary 
group, and 2) that increases in physical activity and fitness in the old would lead to 
enhanced vascular function, such that the old active group would have augmented 
vascular function compared to the older sedentary, and 3) the old endurance trained 
would have a restoration of vascular function, demonstrating augmented vasodilation 
compared to both the old sedentary and old active groups, with no difference compared to 




Subjects were included in this research study based on the following criteria: 1) 
an absence of cardiovascular or metabolic disease, as assessed by a health history 
questionnaire; 2) aged 18-25 yrs for the young, and greater than 65 yrs for the old; and 3) 
sedentary/low physical activity for the young, and three levels of physical activity in the 
old (sedentary/low activity, active, endurance trained). Forty-four healthy men met the 
inclusion criteria for this research study (young sedentary n = 12, old sedentary n = 12, 
old active n = 10, and old endurance trained n = 10). All procedures were approved by 
the Institutional Review Boards of the University of Utah and the Salt Lake City VA 
Medical Center, and written informed consent was obtained from each participant prior to 
inclusion in the study. The study conformed to the standards set by the Declaration of 
Helsinki. 
Experimental Protocol 
Subjects reported to the laboratory on two separate experimental days. On the first 
experimental day, subjects arrived at the laboratory after a light meal. They then 
performed a graded exercise test on a cycle ergometer to volitional exhaustion, during 
which expiratory gasses were collected to determine peak volume of oxygen 
consumption (VO2peak). Prior to departure from the laboratory, the subjects were given an 
accelerometer and instructed on proper operating procedures. All subjects wore the 
accelerometers for a minimum of 7 consecutive days, and returned them on the second 
experimental day.  
The second experimental day took place 7 days after the initial trial. Subjects 
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arrived on the second experimental day fasted and having refrained from caffeine and 
exercise for 24 hours prior to the initiation of data collection. Accelerometers were turned 
in and blood was collected from the antecubital vein to assess blood lipids, fasting 
glucose, and hemoglobin.  
Subjects were then assigned to begin assessments in either the supine or upright-
seated posture using a counterbalanced design. Subjects rested for a minimum of 20 
minutes after instrumentation. Hemodynamic measurements were then collected during 1 
min of baseline with the leg held at a constant 180° knee joint angle, followed by 1 min 
of passive knee flexion-extension through a 90° range of motion (180-90°) at 1 Hz. 
Throughout the protocol, the contralateral leg remained supported and motionless with 
the knee joint extended. PLM was achieved by a member of the research team, with real-
time feedback provided by a position sensor and digital display to ensure full range of 
motion. A metronome, initiated before the start of baseline data collection, was used to 
maintain cadence. Prior to the start and throughout the protocol, participants were 
encouraged to remain passive and to resist the urge to help or hinder the passive 
movement. To avoid the startle reflex, participants were made aware that the passive 
movement would begin in approximately 1 min, but were not told exactly when the 
movement would begin in order to reduce the chance of an anticipatory response (50). 
The protocol was repeated in the opposing body posture (supine or upright-seated) after a 
rest period of at least 20 min in the new posture. 
Measurements 
Central hemodynamics. Heart rate (HR) was determined using an 
electrocardiogram (ECG), and mean arterial pressure (MAP) was determined by finger 
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photoplethysmography with a Finometer (Finapres Medical Systems, Amsterdam, The 
Netherlands) positioned at heart level. Stroke volume (SV) was automatically calculated 
using the Modelflow method (Beatscope, version 1.1; Finapres Medical Systems), with 
cardiac output (CO) calculated as the product of SV and HR.  
Peripheral hemodynamics. Measurements of blood velocity in the common 
femoral artery (CFA) and vessel diameter were performed in the passively moved leg 
distal to the inguinal ligament and proximal to the bifurcation of the superficial and deep 
femoral artery using a Logic 7 ultrasound system (General Electric Medical Systems, 
Milwaukee, WI, USA). The Logic 7 was equipped with a linear array transducer 
operating at an imaging frequency of 14 MHz. CFA diameter was determined at a 
perpendicular angle along the central axis of the scanned area, and blood velocity was 
measured using the same transducer with a frequency of 5 MHz. All blood velocity 
measurements were obtained with the probe appropriately positioned to maintain an 
insonation angle of 60 degrees or less. The sample volume was maximized according to 
vessel size and was centered within the vessel based on real-time ultrasound 
visualization. Using CFA diameter and mean velocity (Vmean) (angle corrected, and 
intensity weighted), leg blood flow (LBF) was automatically calculated by commercially 
available software (Logic 7) as Vmeanπ(vessel diameter/2)2 × 60, where blood flow is in 
milliliters per minute. The PLM-induced peak change in leg blood flow (ΔLBFpeak) was 
calculated as peak LBF minus baseline LBF. Leg vascular conductance (LVC) was 
calculated as LBF divided by MAP. Rapid vasodilation was interpreted as the slope of 
increasing LVC over time for the first 9 s of PLM. Vasodilatory reserve capacity was 
calculated as upright-seated ΔLVCpeak minus supine ΔLVCpeak. The rapid vasodilatory 
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reserve capacity was calculated as the upright-seated LVC slope minus the supine LVC 
slope. Both the vasodilatory reserve capacity and the rapid vasodilatory reserve capacity 
have previously been reported to reflect NO-mediated vasodilatory mechanisms (15). 
Knee joint angle. During each PLM protocol, knee joint angle of the passively 
moved leg was continuously recorded using a Vishay Spectrol 360 degree Smart Position 
Sensor (Vishay Intertechnology Inc., Malvern, PA, USA) mounted on a BREG X2K knee 
brace (BREG Inc., Vista, CA, USA) worn by the participants. 
Anthropometrics. Body mass and height were recorded and used to calculate body 
mass index (BMI) as BMI = body mass x height2, where body mass is measured in 
kilograms and height is measured in meters. Thigh volume of the passively moved leg 
was calculated, as previously described (22), using three measurements of thigh 
circumference (proximal, middle, and distal), thigh length, and skinfold measurements. 
Physical activity and fitness levels. Physical activity level (PAL) was assessed 
using both a modified Minnesota PAL recall questionnaire (31) and objective 
accelerometer data. The PAL questionnaire included items regarding the average type, 
frequency, intensity, and duration of physical activity in any given week. After receiving 
standardized operating instructions, subjects wore an accelerometer (GT1M; Actigraph, 
Pensacola, FL, USA) for a minimum of 7 continuous days, with adherence automatically 
assessed by the device. Average total daily physical activity was expressed as both 
average steps per day, and average total accelerometer counts per minute. The later 
assessment was separated into sedentary, low, moderate, high, and very high intensity 
categories using device specific software (Actilife, Pensacola, FL, USA). Previous 
research has documented the validity and reliability of the Actigraph GT1M in the 
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estimation of daily physical activity (1, 51). Older subjects were initially separated into 
the three physical activity groups (sedentary/low activity, active, endurance trained) 
based on their responses to the PAL questionnaire. Grouping was then confirmed 
utilizing both steps per day and accelerometer counts per minute (36, 48). 
Fitness level was determined by a cycling VO2peak test performed on an 
electronically braked cycle ergometer (Lode, Groningen, The Netherlands), and 
pulmonary VO2 was measured continuously throughout the test (Parvomedics, Sandy, 
UT). The VO2peak protocol consisted of a 1 min warm-up at 25 watts followed by an 
incremental increase of 25 watts each minute until volitional exhaustion (3). Criteria for 
successful attainment of VO2peak were a respiratory exchange ratio of >1.1, and the 
achievement of a maximal HR within 10 beats/min of the predicted value (220-age). 
VO2peak was considered the highest 30 s average prior to cessation of exercise. Results 
from the cycling VO2peak test provided additional confirmation of appropriate subject 
grouping. 
Data Acquisition and Statistical Analysis 
Throughout each protocol ECG, SV, CO, MAP, and knee joint angle signals 
underwent analog-to-digital conversion and were simultaneously acquired (200 Hz) using 
commercially available data acquisition software (AcqKnowledge, Biopac Systems Inc., 
Goleta, CA, USA). CFA diameter and Vmean were acquired on the ultrasound system (GE 
Logic 7). Baseline was analyzed using the average of the 60 s prior to the initiation of 
PLM. All variables were analyzed second-by-second for the 60 s of passive movement, 
and data were smoothed using a 3 s rolling average prior to final data analysis. Multiple 
2x4 repeated measures ANOVA were used to determine significant differences in 
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baseline and the absolute change from baseline to peak for HR, SV, CO, MAP, LBF, 
LVC, and LVC slope, and Tukey’s HSD was used for post hoc analysis. A one-way 
ANOVA (1x4) was used to determine group differences in vasodilatory and rapid 
vasodilatory reserve capacity. Student’s t-tests were used for subject characteristics and 
significance was set at an α-level of 0.05. Data are presented as mean ± SEM. 
Results 
Subjects 
The differences in the subject characteristics between groups, displayed in Table 
3.1, were anticipated based on their respective physical activity and fitness levels. 
Physical activity and fitness comparisons are displayed in Table 3.2 and Figure 
3.1. Total daily physical activity, as assessed by both accelerometer counts/min and 
steps/day, was not different between young and old sedentary subjects (Figure 3.1, A and 
B). As previously reported (16), the similar total daily physical activity between these 
two groups was achieved in differing ways. Old sedentary subjects spent more time 
engaged in low intensity physical activity (~ 60 min/day), while young subjects spent 
more time in the moderate intensity category (~ 20 min/day, Table 3.2). In contrast, both 
absolute and relative VO2peak were attenuated in the old compared to the young sedentary 
subjects (Figure 3.1, C and D). The old active subjects had greater activity counts/min 
and steps/day compared to both the young and old sedentary, greater time spent in the 
moderate and vigorous intensity categories compared to old sedentary (Table 3.2), and a 
higher VO2peak than the old sedentary, but still demonstrated attenuated absolute and 
relative VO2peak compared to the young sedentary subjects (Figure 3.1, C and D). The old 
endurance trained group had significantly greater activity counts/min, steps/day, time 
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spent in the moderate and vigorous intensity categories, and absolute and relative VO2peak 
compared to both the young and old sedentary subjects. While the old active and old 
endurance trained groups took a similar number of steps/day, the old endurance trained 
group tended (p = 0.06) to spend more time in the vigorous intensity category compared 
to the old active, resulting in greater activity counts/min, and an augmented absolute and 
relative VO2peak compared to the old active (Figure 3.1, B, C and D). 
Central and Peripheral Hemodynamics During Rest and PLM 
Central hemodynamics. At rest, MAP, CO, SV, and HR were similar between 
groups and body postures (Table 3.3). In response to PLM, the old trained group had less 
of an increase in HR in both the supine and upright-seated postures compared to the old 
sedentary. All other central hemodynamic responses to PLM were similar between 
groups and body postures. 
Peripheral hemodynamics. At rest, the old sedentary group had lower LBF and 
LVC compared to the young in both the supine and upright-seated postures (Table 3.3). 
In response to PLM, the ΔLBFpeak in the supine posture was not different between these 
groups, although tending to be lower in the old sedentary compared to the young subjects 
(p = 0.11, Table 3.3). Similarly, the ΔLVCpeak was not different between the three old 
groups, or when comparing the young to the old active and old endurance trained groups, 
but was significantly lower in the old sedentary compared to the young (Table 3.3, Figure 
3.2C). The upright-seated posture augmented the PLM response (ΔLBFpeak and 
ΔLVCpeak) in the young, old active, and old endurance trained groups, with no effect in 
the old sedentary (p = 0.93 and p = 0.73, respectively), such that ΔLBFpeak and ΔLVCpeak 
were significantly greater in the young, old active, and old endurance trained compared to 
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the old sedentary (Table 3.3, Figure 2D). However, while the old active and old 
endurance trained groups displayed an upright-seated posture-induced increase in the 
PLM response, the ΔLBFpeak and ΔLVCpeak remained attenuated compared to the young 
sedentary subjects. 
The young, old active, and old endurance trained groups all demonstrated a 
significant vasodilatory reserve capacity (young sedentary: 4.92 ± 1.18, old active: 1.37 ± 
0.55, old endurance trained: 2.76 ± 0.95 ml/min/mmHg; p < 0.05), while the old 
sedentary group was unable to take advantage of the posture-induced increase in FPP in 
terms of vasodilation (old sedentary: -0.34 ± 0.41; p = 0.73; Figure 3.3). Compared to the 
young, the old sedentary and old active groups displayed an attenuated vasodilatory 
reserve capacity, while the old endurance trained group’s response was not significantly 
different from the young (p = 0.27). Due to the complete lack of a vasodilatory reserve 
capacity in the old sedentary group, both the old active and old endurance trained groups 
had a significantly greater vasodilatory reserve capacity compared to the old sedentary. 
The rapid vasodilatory response in the supine posture was attenuated in the old 
sedentary compared to the young (young sedentary: 0.69 ± 0.08, old sedentary: 0.38 ± 
0.06 ml/min/mmHg/s; p < 0.05; Figure 3.4A), with no other differences between groups 
(old active: 0.55 ± 0.10, old endurance trained: 0.50 ± 0.06 ml/min/mmHg/s; p > 0.05). 
Moving from the supine to the upright-seated posture significantly augmented the rapid 
vasodilation in the young, old active, and old endurance trained (1.08 ± 0.14, 0.75 ± 0.10, 
0.86 ± 0.13 ml/min/mmHg/s, respectively; p < 0.05 for all), with no change in the old 
sedentary group (0.42 ± 0.06 ml/min/mmHg/s; p = 0.44), such that the rapid vasodilation 
in the upright-seated posture in the old sedentary was attenuated compared to all three 
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groups (Figure 3.4B). Despite the posture-induced increase in rapid vasodilation in the 
old active, the response in the young was of a greater magnitude, leading to a significant 
difference between these two groups. However, there was no difference in the rapid 
vasodilation between the young sedentary and old endurance trained subjects while in the 
upright-seated posture (p = 0.17). When comparing the posture-induced increase in the 
LVC slope between groups (rapid vasodilatory reserve capacity, Figure 3.4C), a similar 
qualitative pattern was observed as that for the vasodilatory reserve capacity. While there 
were no significant differences between the groups, both the young and old endurance 
trained tended to display a greater rapid vasodilatory reserve capacity compared to the 
old sedentary (p = 0.10 and p = 0.11, respectively). 
Discussion 
Utilizing the novel PLM assessment, we sought to elucidate the impact of 
increased physical activity and fitness on vascular function with advancing age. Among 
the old subjects, elevated levels of physical activity and fitness had a positive effect on 
PLM-induced vasodilation in the upright-seated posture. Furthermore, the vasodilatory 
reserve capacity and rapid vasodilatory reserve capacity appear to be affected in a dose-
dependent manner by physical activity and fitness, resulting in significantly improved 
vascular function in the old active and old endurance trained, compared to their sedentary 
peers. Finally, while the upright-seated ΔLVCpeak in the old endurance trained was not 
completely restored to the level of the young, both the vasodilatory reserve capacity and 
rapid vasodilatory reserve capacitiy, reported to be highly NO-dependent, were similar 
between these two groups. Consequently, utilizing the novel PLM assessment of vascular 
function, these findings suggest that increasing levels of physical activity and fitness can 
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improve NO bioavailability and reduce the deleterious effects of advancing age on 
vascular function. 
Age and Attenuated NO-Mediated Vascular Function 
NO is an endothelium derived vasodilator that is synthesized in response to a 
number of stimuli, including endothelial cell deformation and luminal shear forces (10, 
11, 40). In addition to its role as a vasodilator, NO prevents atherogenesis by inhibiting 
platelet aggregation, white blood cell adhesion, and vascular smooth muscle cell 
migration and proliferation (23, 25). Therefore, NO is a critically important molecule in 
limiting the progression of CVD, suggesting that measuring NO bioavailability may 
provide insight into CVD risk across the human lifespan.  
A preponderance of evidence collected in the human arm demonstrates that 
healthy aging is associated with reduced NO-mediated vascular function (2, 7, 26, 29, 41, 
44). Indeed, when the endothelium- and NO-dependent vasodilator ACh is infused into 
the brachial artery of young and old sedentary subjects, the vasodilatory response is 
attenuated in the old (7, 41). In contrast, infusion of sodium nitroprusside, an 
endothelium- and NO-independent vasodilator, results in similar levels of vasodilation in 
both young and old subjects, indicating that the attenuated vasodilation with age is a 
consequence of diminished endothelial NO bioavailability (7, 41). Seemingly in 
agreement with these findings, the percent dilation of the brachial artery in response to 
post-occlusion-induced increases in wall shear stress (FMD), demonstrate that the 
vasodilatory response is attenuated with age (6, 9, 28). However, brachial artery 
remodeling with age leads to increased lumen diameter in old subjects (4, 14), which 
confounds the calculation of FMD as a percentage change from baseline and reduces 
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endothelial shear forces that cause the brachial artery to dilate. Indeed, when brachial 
artery dilation is normalized for the shear stimulus, the difference between young and old 
frequently disappears (28, 53), which would suggest that vascular function is preserved 
with age, a finding that contradicts data from investigations using ACh infusions. 
Furthermore, the current literature questions the role of brachial artery FMD as a marker 
of NO-mediated vasodilation (35, 47, 54), and indicates that the lower limbs, which are 
more susceptible to age-related vascular dysfunction, may be a more appropriate site to 
study alterations in NO bioavailability with age (8, 27, 52). 
PLM, a leg movement model essentially devoid of increases in metabolism and 
therefore metabolically-mediated vasodilation causes a robust vasodilation-induced 
increase in LBF and LVC, the magnitude of which is attenuated with age (16, 24). When 
the eNOS inhibitor NG-monomethyl-L-arginine (L-NMMA) is infused into the common 
femoral artery during PLM, the vasodilatory response is reduced by ~80% in the young, 
indicating that the PLM-induced vasodilation is predominantly NO-mediated (15, 26, 
46). Furthermore, eNOS inhibition has little effect on the already attenuated PLM 
response in old sedentary subjects, suggesting that reduced NO bioavailability is largely 
responsible for the age-related decrease in vascular function assessed by this novel 
approach (15, 46). The current investigation once again supports this previous work by 
demonstrating an age-associated attenuation in the PLM-induced ΔLBFpeak and ΔLVCpeak 
in the old sedentary men in both the supine and upright-seated postures (Table 3.3, Figure 
3.2). Furthermore, the vasodilatory reserve capacity and the rapid vasodilatory reserve 
capacity, both of which are suggested to be primarily NO-dependent (15), were 
essentially absent in the old sedentary men, providing additional evidence in support of 
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the suggestion that the attenuated PLM response with age is due to reduced NO 
bioavailability. However, whether the PLM-induced vasodilation is protected in older 
individuals who maintain a greater level of physical activity and fitness has not 
previously been investigated. 
Impact of Physical Activity and Fitness on Vascular Function with Age 
Aging is associated with increased formation of atherosclerotic plaques, which 
may result, in part, from alterations in the arterial blood flow profile towards a 
proatherogenic state (5, 30, 45, 55). This proatherogenic blood flow profile is 
characterized by lower anterograde flow, higher retrograde flow, and greater endothelial 
oscillatory shear forces, all of which lead to attenuated NO bioavailability and impaired 
endothelium-dependent vasodilation (20, 39, 43, 49). An acute bout of endurance 
exercise increases anterograde blood flow, decreases retrograde blood flow, and 
decreases oscillatory shear both during and directly after the exercise bout (18, 42). 
Therefore, endurance exercise creates an antiatherogenic blood flow pattern that has been 
documented to acutely increase eNOS phosphorylation and chronically increase eNOS 
protein expression, leading to greater NO bioavailability (10, 14, 17, 29). Indeed, the 
forearm vascular conductance response to doubling doses of ACh is very similar between 
old endurance trained and young sedentary men (7, 27), and 3 months of exercise training 
in previously sedentary old men can restore their ACh response to that of young 
sedentary and old endurance trained men (7). However, results in terms of the effect of 
endurance exercise training in the old on brachial artery FMD are mixed, with some 
reporting improved vasodilation (9, 33), and others reporting no change (4, 34). These 
contradictory findings may be due to the confounding effects of arterial remodeling in 
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response to chronic exercise training that results in a greater baseline luminal diameter 
(13, 14). Indeed, in the current investigation, the old endurance trained tended to have a 
larger CFA diameter compared to their sedentary peers (p = 0.07, Table 3.1), but as PLM 
does not rely upon changes in CFA diameter, per se, to assess vascular function, this is 
not a confounding issue in the current study. 
Utilizing the PLM model, the impact of physical activity and fitness on vascular 
function is clear. Both the active and endurance trained old groups exhibited significantly 
augmented PLM-induced ΔLVCpeak, vasodilatory reserve, and upright-seated rapid 
vasodilation compared to the old sedentary (Figures 3.2, 3.3, and 3.4, respectively). 
Furthermore, to our knowledge, this is the first study to assess two different levels of 
physically active old subjects, allowing the effect of a physical activity and fitness “dose 
response” on vascular function to be assessed. In this regard, in terms of the PLM-
induced ΔLVCpeak, it would appear that higher levels of physical activity and fitness in 
the old endurance trained group had no additional benefit on vascular function above and 
beyond that exhibited by the old active group (Figure 3.2). However, the vasodilatory 
reserve capacity, which remained attenuated in the old active compared to the young, was 
improved in the old endurance trained to the point that this group’s vasodilatory reserve 
capacity was no longer different from the young, suggesting that there is some additional 
augmentation of NO-mediated vasodilation with greater physical activity and fitness in 
the old (Figure 3.3).  
Further evidence from the assessment of the rapid vasodilatory response supports 
the restorative or protective role of greater levels of physical activity and fitness in the 
old. Specifically, while both the old active and old endurance trained displayed a posture-
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induced augmentation of the rapid vasodilatory response, this response was only similar 
in the young and old endurance trained subjects (Figure 3.4B). Furthermore, analysis of 
the rapid vasodilatory reserve capacity provides an additional examination of the effect of 
posture on the rapid vasodilatory response (Figure 3.4C). While this method of analysis 
created additional variance, resulting in no statistically significant differences between 
groups, it appears that there is a stepwise increase in the rapid vasodilatory reserve 
capacity with greater levels of physical activity and fitness among the old groups, such 
that the response in old endurance trained tended to be greater than the old sedentary, and 
was very similar to the young.  
Together, these findings indicate that the reduction in NO bioavailability with age 
can be mitigated in older populations who possess greater levels physical activity and 
fitness. Additionally, the PLM assessment of vascular function, which is not confounded 
by age and chronic exercise-induced changes in arterial structure, is capable of detecting 
alterations in vascular function among old individuals of varying physical activity and 
fitness levels. 
Conclusion 
Utilizing the novel PLM assessment of vascular function, the results of the current 
investigation support previous findings that aging has a deleterious effect on vascular 
function in otherwise healthy, sedentary humans. Furthermore, this study adds to the 
literature by demonstrating that higher levels of physical activity and fitness can partially 
restore or protect against this age-associated decrease in PLM-induced vasodilation. The 
observation that the upright-seated ΔLVCpeak, PLM-induced vasodilatory reserve 
capacity, and rapid vasodilatory reserve capacity are predominantly NO dependent in the 
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young suggests that the reduced vascular function with age is due to decreased NO 
bioavailability, which can be protected by increasing levels of physical activity and 
fitness with advancing age. 
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Table 3.1 Subject characteristics 
BMI, body mass index; CFA diameter, common femoral artery diameter; HDL, high 
density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol. # p < 0.05, 
significantly different from the young; § p < 0.05, significantly different from the old 
sedentary; † p < 0.05, significantly different from the old active. Values are mean ± SEM. 
n 12 12 10 10
Age (y) 23 ± 1 73 ± 2# 71 ± 2# 72 ± 1#
Height (cm) 176 ± 2 176 ± 1 180 ± 2 177 ± 1
Weight (kg) 75 ± 3 82 ± 4 77 ± 3 71 ± 1§
BMI (kg/m2) 24.2 ± 0.9 26.4 ± 1.1 24.0 ± 0.6 22.6 ± 0.4§
Thigh Volume (dl) 70 ± 3 65 ± 3 66 ± 3 67 ± 2
CFA Diameter (cm) 0.90 ± 0.02 1.01 ± 0.05# 1.10 ± 0.06# 1.15 ± 0.04#
Glucose (mg/dl) 72 ± 3 73 ± 3 81 ± 3 90 ± 4#§
Cholesterol (mg/dl) 163 ± 12 182 ± 8 178 ± 8 197 ± 11
Triglycerides (mg/dl) 114 ± 29 93 ± 11 73 ± 6 56 ± 2§†
HDL (mg/dl) 45 ± 3 50 ± 3 54 ± 4# 86 ± 5#§†
LDL (mg/dl) 101 ± 9 117 ± 7 113 ± 7 111 ± 6
Haemoglobin (g/dl) 15.8 ± 0.3 15.3 ± 0.2 15.0 ± 0.4 14.7 ± 0.3#
Maximum Work Rate (W) 235 ± 11 175 ± 14# 230 ± 16§ 275 ± 19§
Old Trained
Table 1:  Subject Characteristics
Young Old Sedentary Old Active
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Table 3.2 Intensity of physical activity 
Average time spent in five physical activity categories per day (min/day). Young 
sedentary n = 12, old sedentary n = 12, old active n = 10, old endurance trained n = 10. # 
p < 0.05, significantly different from the young; § p < 0.05, significantly different from 
the old sedentary. Values are mean ± SEM. 
 
Sedentary (min/day) 1217 ± 20 1178 ± 25 1189 ± 16 1206 ± 11
Light (min/day) 186 ± 19 249 ± 24# 195 ± 18 156 ± 9§
Moderate (min/day) 34 ± 3 12 ± 3# 45 ± 6§ 56 ± 8#§
Vigorous (min/day) 2 ± 1 1 ± 0 9 ± 4§ 21 ± 4#§
Very Vigorous (min/day) 0.7 ± 0.5 0.5 ± 0.5 1.1 ± 1.0 0.9 ± 0.3
#p<0.05 compared to Young
§p<0.05 compared to Old Sedentary
†p<0.05 compared to Old Active
Table 2:  Intensity of Physical Activity














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.1 Physical activity and fitness levels. Average steps taken per day (A); Total 
daily physical activity (B, activity counts/min); both steps per day and total daily physical 
activity were assessed as the average from at least 7 days of accelerometry; Absolute (C, 
l/min) and relative (D, ml/kg/min) volume of oxygen consumed at peak exercise during a 
graded cycling test to volitional exhaustion. Young sedentary n = 12, old sedentary n = 
12, old active n = 10, old endurance trained n = 10. # p < 0.05, significantly different 
from the young; § p < 0.05, significantly different from the old sedentary; † p < 0.05, 
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Figure 3.2 Passive leg movement (PLM)-induced changes in leg vascular conductance in 
the supine and upright-seated posture with age and across physical activity and fitness 
levels. Second-by-second tracing of the change in leg vascular conductance 
(ml/min/mmHg) throughout 1 min of PLM in the supine (A) and upright-seated (B) 
postures; peak change in LVC from baseline (ΔLVCpeak, ml/min/mmHg) in the supine 
(C) and upright-seated (D) postures. Young sedentary n = 12, old sedentary n = 12, old 
active n = 10, old endurance trained n = 10. * p < 0.05, significantly different from the 
supine posture.  # p < 0.05, significantly different from the young; § p < 0.05, 
significantly different from the old sedentary. Values are mean ± SEM.
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Figure 3.3 Passive leg movement (PLM)-induced vasodilatory reserve capacity with age 
and across physical activity and fitness levels. The difference in the PLM-induced peak 
change in leg vascular conductance (∆LVCpeak, ml/min/mmHg) between the supine and 
upright-seated posture (vasodilatory reserve capacity). Young sedentary n = 12, old 
sedentary n = 12, old active n = 10, old endurance trained n = 10. # p < 0.05, significantly 
different from the young; § p < 0.05, significantly different from the old sedentary. 
Values are mean ± SEM. 
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Figure 3.4 Passive leg movement (PLM)-induced rapid vasodilation in the supine and 
upright-seated posture with age and across physical activity and fitness levels. The rate of 
increase in the leg vascular conductance (LVC, ml/min/mmHg) over time was 
determined for the first 9 s of PLM in the supine (A) and upright-seated (B) postures; C, 
the difference in the slope between the supine and upright-seated posture (rapid 
vasodilatory reserve capacity, ml/min/mmHg/s). Young sedentary n = 12, old sedentary n 
= 12, old active n = 10, old endurance trained n = 10. * p < 0.05, significantly different 
from the supine posture.  # p < 0.05, significantly different from the young; § p < 0.05, 





DECREASED PASSIVE LEG MOVEMENT-INDUCED VASODILATION WITH 
AGE: THE IMPACT OF ACUTE ANTIOXIDANT SUPPLEMENTATION 
Abstract 
Passive leg movement (PLM)-induced vasodilation, a noninvasive measure of 
nitric oxide (NO)-mediated vasodilation, whether performed supine or upright to 
augment the contribution of NO, is attenuated with age. To examine the role of oxidative 
stress, supine and upright-seated PLM was performed in 15 young (22±1 yrs) and 17 old 
(72±2 yrs) healthy subjects after ingestion of an antioxidant cocktail (AOC, Vitamins C, 
E, and alpha-lipoic acid) or placebo. Hemodynamics were measured utilizing ultrasound 
Doppler and finger photoplethysmography. With placebo, PLM-induced peak change in 
leg vascular conductance (ΔLVCpeak) was significantly attenuated with age in both the 
supine (young: 6.6±0.7, old: 3.8±0.5 ml/min/mmHg) and upright-seated (young: 
10.7±1.2, old: 3.7±0.7 ml/min/mmHg) posture. Although the old subjects had greater 
inflammation than the young (plasma Interleukin 6 (~ 335%) and C-reactive protein (~ 
180%)), lipid peroxidation (malanaldehyde, MDA) was similar while plasma protein 
carbonyl levels tended to be higher in the old (~25%) compared to the young (p = 0.08). 
The AOC significantly improved antioxidant status in the young and old (plasma 
ascorbate and ferric reducing ability of plasma (FRAP)), and significantly attenuated lipid 
peroxidation (MDA). However, the AOC had no effect on the vasodilatory response to 
PLM in either group or posture (young supine: 7.1±1.0, young upright-seated: 10.8±1.4; 
old supine: 3.9±0.6, old upright-seated: 4.2±0.8 ml/min/mmHg). Therefore, vascular 
dysfunction persists in older adults despite an AOC-induced increase in antioxidant status 
and attenuated oxidative stress, questioning the direct role of redox balance in the 
apparent age-related decrease in NO bioavailability in the lower limbs. 
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Introduction 
The impact of aging on cardiovascular disease (CVD) progression depends, to 
some extent, upon the health and function of the endothelium and, specifically, the 
bioavailability of the endothelium-derived vasodilator NO (23). NO is recognized to be 
antiatherogenic (25, 31), and NO bioavailability appears to fall with age (1, 9, 39). While 
the mechanisms leading to this age-related decline in NO bioavailability are not fully 
understood, one possible explanation is increased levels of free radicals, such as 
superoxide (O2-), resulting in NO scavenging and oxidative stress.  
With age, pro-oxidant markers have been recognized to increase both in 
endothelial cells and circulating plasma and are associated with diminished endothelium-
dependent vasodilation (7, 44), while the infusion of the antioxidant ascorbic acid in such 
subjects improves NO bioavailability and vasodilation assessed in the arm (10, 38, 39). 
Utilizing an AOC, our group has also demonstrated that lowering plasma markers of 
oxidative stress enhances endothelial function in the brachial artery of old subjects, as 
assessed by flow mediated vasodilation (FMD) (44). Thus, the literature provides 
compelling evidence that elevated free radical levels contribute to the attenuated vascular 
function observed in the arm with advancing age. However, somewhat surprisingly, to 
our knowledge, there is not a single study that has examined the role of oxidative stress 
on endothelium-dependent vasodilation in the lower limbs with age, where peripheral 
vascular disease is most common. 
PLM, a novel tool for assessing vascular function, has recently been documented 
to reflect NO-mediated vasodilation in the lower limbs of young men (28, 41). In old 
subjects, the PLM-induced vasodilation is blunted compared to the young, primarily due 
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to a reduction in NO bioavailability (40). An additional feature of PLM is the opportunity 
to use posture (supine to upright-seated) to increase femoral perfusion pressure (FPP) 
(15) and potentially augment the role of NO in the vasodilatory response (14, 15). Indeed, 
in the young, this maneuver amplifies the rapid (first 9 s) vasodilatory response as well as 
the peak vasodilatory response to PLM, and reveals an NO-dependent vasodilatory 
reserve capacity (the difference in leg vascular conductance peak change (ΔLVCpeak) 
from supine to upright-seated posture). However, likely due to limited NO 
bioavailability, the old are unable to take advantage of this additional FPP-driven 
stimulus to vasodilate (14, 15). The underlying mechanism for this diminished NO-
mediated vasodilation during PLM in the old is currently unknown, but could be related 
to the elevated oxidative stress typically associated with aging. 
Consequently, utilizing PLM in both the supine and upright-seated posture to 
assess vascular function, we sought to determine the impact of acute AOC 
supplementation on the vasodilatory response in young and old subjects. We 
hypothesized that, due to a more pro-oxidant state and subsequently increased NO 
scavenging in the old, the AOC would 1) rescue the decreased PLM-induced vasodilation 
in the old in both body postures, 2) restore the NO-mediated component of the rapid 
vasodilatory response and the vasodilatory reserve capacity in the old, and 3) have no 





32 healthy subjects (15 young, 17 old) participated in this study. Subjects were 
included based on an absence of overt cardiovascular or metabolic disease, and aged 18-
25 yrs for the young, and greater than 65 yrs for the old. Subjects refrained from taking 
any vitamin supplements for 7 days prior to enrolment in the study, and throughout the 
study period. All procedures were approved by the Institutional Review Boards of the 
University of Utah and the Salt Lake City VA Medical Center, and written informed 
consent was obtained from each participant prior to inclusion in the study. The study 
conformed to the standards set by the Declaration of Helsinki. 
Experimental Protocol 
All subjects participated in a familiarization trial and two experimental trials, each 
performed on separate days. During the familiarization trial, instrumentation followed by 
PLM was performed to both acquaint subjects with the experimental procedures and to 
ensure their ability to remain relaxed throughout the protocol. Prior to arrival for the 
experimental trials, subjects received either the AOC or placebo (PL) in a 
counterbalanced, single-blind, cross-over design. 
Subjects reported to the experimental trials fasted and having refrained from 
caffeine for 12 and 24 hours prior, respectively. All young females were studied within 
the first 7 days (follicular phase) of the menstrual cycle to control for variations in 
circulating hormones, and all older females were self-confirmed postmenopausal. Blood 
samples were obtained from the antecubital vein to assess metabolic and blood cell 
parameters, as well as markers of oxidant and antioxidant status. Subjects were then 
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randomly assigned to begin in either the supine or upright-seated posture, instrumented, 
and allowed to rest for at least 20 min prior to initiation of the PLM protocol. Central and 
peripheral hemodynamic measurements were then collected for 1 min of baseline with 
the experimental leg supported at 180° knee joint angle, followed by 1 min of PLM 
through a 90° range of motion at a rate of 1 Hz. The contralateral leg remained 
motionless and supported at 180° knee joint angle throughout the protocol. PLM was 
performed by a member of the research team with real-time feedback provided by a 
position sensor and digital display to ensure full range of motion. A metronome, initiated 
prior to the start of baseline data collection, was used to maintain cadence. Prior to the 
start and throughout the protocol, subjects were encouraged to remain passive and resist 
the urge to help or hinder the movement. The PLM protocol was repeated in the opposing 
body posture (supine of upright-seated) after a rest period of at least 20 min in the new 
posture. These procedures were repeated on the second experimental day under the 
opposing supplement condition (AOC or PL). 
Antioxidant Supplementation 
Prior to arrival for the experimental trials, subjects received either AOC or PL in a 
counterbalanced, single-blind, crossover design. The AOC was administered in 2 doses, 
separated by 30 min, to improve absorption and maintain the time of antioxidant efficacy. 
The first dose was taken 90 min prior to the PLM protocol and consisted of 500 mg of 
Vitamin C, 200 IU of Vitamin E, and 300 mg of alpha-lipoic acid. The second dose, 
taken 60 min prior to PLM, consisted of 500 mg of Vitamin C, 400 IU of Vitamin E, and 
300 mg of alpha-lipoic acid. Previously, this AOC and the dosing protocol, has been 
documented to lower the abundance of oxygen centered free radicals, as measured by 
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electron paramagnetic resonance spectroscopy, and improve vascular function (33). The 
PL consisted of microcrystalline cellulose capsules of similar taste and appearance, 
administered in 2 doses with identical time frame to the AOC. 
Measurements 
Central hemodynamic variables. Heart rate (HR) was determined using an 
electrocardiogram (ECG), while mean arterial pressure (MAP), stroke volume (SV), and 
cardiac output (CO) were assessed using finger photoplethysmography with a finometer 
(Finapres Medical Systems, Amsterdam, The Netherlands) positioned at heart level. SV 
was calculated using the model flow method (Beatscope, version 1.1; Finapres Medical 
Systems), and CO was calculated as the product of SV and HR. 
Peripheral hemodynamic variables. Measurements of blood velocity and vessel 
diameter were performed in the common femoral artery of the passively moved leg, distal 
to the inguinal ligament and proximal to the bifurcation of the superficial and deep 
femoral artery using a Logic 7 ultrasound system (General Electric Medical Systems, 
Milwaukee, WI, USA). The Logic 7 was equipped with a linear array transducer 
operating at an imaging frequency of 14 MHz. Common femoral artery diameter was 
determined at a perpendicular angle along the central axis of the scanned area, and blood 
velocity was measured using the same transducer with a frequency of 5 MHz. All blood 
velocity measurements were obtained with the probe appropriately positioned to maintain 
an insonation angle of 60° or less. The sample volume was maximized according to 
vessel size and was centered within the vessel based on real-time ultrasound 
visualization. Using common femoral artery diameter and mean velocity (Vmean) (angle 
corrected, and intensity weighted), leg blood flow was automatically calculated by 
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commercially available software (Logic 7) as Vmeanπ(vessel diameter/2)2 × 60, where 
blood flow is in milliliters per minute. LVC was calculated as leg blood flow divided by 
MAP, and ΔLVCpeak was calculated as peak LVC minus baseline LVC. 
Blood assays. Plasma and serum samples were stored at -80° until analysis. Both 
plasma IL6 and CRP (R&D Systems, Inc., Minneapolis, MN), indicators of systemic 
inflammation, were only measured under PL conditions, as they would not be expected to 
change with acute AOC supplementation. The efficacy of the AOC supplementation 
protocol, in terms of Vitamin C delivery, was determined from plasma ascorbate 
concentration (CosmoBio, Carlsbad, CA) and total antioxidant capacity was assessed by 
the ferric reducing ability of plasma (FRAP) assay, using the method of Benzie and 
Strain (3). Enzymatic antioxidant activity, assessed by superoxide dismutase (SOD), was 
also assayed in the plasma (43) (Cayman Chemical Company, Ann Arbor, MI). Lipid 
peroxidation was assessed by plasma malondialdehyde levels (MDA, Bioxytech LPO-
586, Foster City, CA), while protein oxidation was evaluated by plasma protein carbonyl 
levels (Bloodworks Northwest, Seattle, WA). Glucose, lipids, and a complete blood cell 
count were performed using standard techniques. 
Knee joint angle. During each protocol, knee joint angle of the passively moved 
leg was continuously recorded using a Vishay Spectrol 360 degree Smart Position Sensor 
(Vishay Intertechnology Inc., Malvern, PA, USA) mounted on a BREG X2K knee brace 
(BREG Inc., Vista, CA, USA) worn by the participants. 
Anthropometrics and physical activity. Body mass and height were recorded and 
used to calculate body mass index (BMI) as BMI = body mass x height2, where body 
mass is measured in kilograms and height is measured in meters. Thigh volume of the 
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passively moved leg was calculated, as previously described (24), using three 
measurements of thigh circumference (proximal, middle, and distal), thigh length, and 
skinfold measurements. Physical activity level was assessed using accelerometry and 
expressed as both total activity counts per minute and total steps per day. 
Data Acquisition and Statistical Analysis 
Throughout each protocol ECG, SV, CO, MAP, and knee joint angle signals 
underwent analog-to-digital conversion and were simultaneously acquired (200 Hz) using 
commercially available data acquisition software (AcqKnowledge, Biopac Systems Inc., 
Goleta, CA, USA). Common femoral artery diameter and Vmean were acquired with the 
ultrasound system (GE Logic 7). Baseline was analyzed using the average of the 60 s 
prior to the initiation of PLM. All variables were analyzed second-by-second for the 60 s 
of PLM, and data were smoothed using a 3 s rolling average prior to final data analysis. 
2x2x2 repeated measures ANOVA were used to determine significant differences at 
baseline and in the absolute change from baseline to peak for HR, SV, CO, MAP, LBF 
and LVC, as well as for the slope of LVC across time for the first 9 s of PLM. A 2x2 
repeated measures ANOVA was used to compare the vasodilatory reserve capacity 
between groups and conditions, and student’s t-tests were utilized for subject 
characteristics. Significance was set at an α-level of 0.05, and all data are presented as 




 Subject characteristics are displayed in Table 4.1. Body mass and BMI were 
significantly higher in the older group compared to the young, but thigh volume was not 
different. Fasting blood glucose and total cholesterol were significantly higher in the 
older group, but glucose levels remained within the recommended range. Hemoglobin 
was similar between groups, as was the complete blood cell count, with the exception of 
Lymphocytes, which were lower in the old. Both IL6 and CRP levels were significantly 
elevated in the older group. Total physical activity, expressed as both activity counts per 
minute and steps per day, tended to be lower in the old, but this did not reach statistical 
significance (p = 0.08 and p = 0.09, respectively). 
 
Oxidant/Antioxidant Status 
 Plasma Vitamin C, FRAP, and MDA levels are displayed in Figure 4.1. Vitamin 
C levels increased significantly with the AOC in both the young and the old (~61% and 
~48%, respectively, p < 0.05), with no difference between groups during either the PL or 
AOC condition. Additionally, FRAP was significantly increased with the AOC (young: 
~4%; old: ~7%; p < 0.05), and MDA was significantly decreased with the AOC (young: 
~6%; old: ~8%, p < 0.05), but neither FRAP nor MDA were different between groups 
during either the PL or the AOC condition. Plasma protein carbonyl levels tended to be 
higher in the old (~25%) compared to the young in the PL condition, but this did not 
reach statistical significance (young: 0.1 ± 0.005; old: 0.124 ± 0.009 η/ml; p = 0.08). The 
AOC did not have a significant effect on protein carbonyl levels in either the young or the 
old, but the tendency for higher levels in the old was no longer evident (young: 0.105 ± 
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0.01; old: 0.115 ± 0.008 η/ml), p = 0.55). Plasma SOD activity was not different between 
the young and the old in the PL condition (young: 13.7 ± 2.4; old: 13.6 ± 0.05 IU/ml, p = 
0.88), and, although tending to increase with the AOC in the old (~5%, p = 0.09), 
remained undifferentiated compared to the young (young: 14.3 ± 0.08; old: 14.9 ± 0.7 
IU/ml), p = 0.65). 
Central Hemodynamics at Rest and in Responses to PLM 
Central hemodynamic variables are displayed in Table 4.2. During resting 
baseline, MAP was significantly greater in the old compared to the young during all 
conditions except the upright-seated AOC condition, which tended to be elevated with 
age (P = 0.06). There were no age, posture, or condition effects evident during resting 
baseline for CO, SV, or HR. During PLM in the old, the ΔMAPpeak during both the PL 
and AOC condition in the supine posture decreased to a greater extent compared to the 
young, with no age-related difference in ΔMAPpeak in the upright-seated posture. There 
were no differences between age groups in ΔCOpeak, ΔSVpeak, or ΔHRpeak responses to 
PLM for either body posture or condition. 
Peripheral Hemodynamics at Rest and in Responses to PLM 
Peripheral hemodynamic variables are displayed in Table 4.2. During resting 
baseline, LBF and LVC were attenuated in both the PL and AOC conditions in both body 
postures. In the young, LBF and LVC were elevated during the AOC condition in the 
supine posture, and LVC was significantly lower in the upright-seated compared to 
supine posture during the AOC condition only. In the old, the AOC had no effect on 
resting LBF or LVC. PLM resulted in a significant increase in LBF and LVC in both age 
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groups and across all trials. In the supine posture, the PLM-induced ΔLBFpeak and 
ΔLVCpeak were attenuated with age during both the PL (ΔLBFpeak: ~40%, P=0.07; 
ΔLVCpeak: ~42%, p < 0.05) and the AOC condition (ΔLBFpeak: ~45%, P<0.05; ΔLVCpeak: 
~45%, p = 0.06; Table 4.2, Figure 4.2A and B). In the young, the upright-seated posture 
significantly augmented the ΔLBFpeak and ΔLVCpeak during both PL and AOC conditions 
(p < 0.05), with no change in either the PL or AOC condition in the old (Table 4.2, 
Figure 4.2C & D). Therefore, the ΔLBFpeak and ΔLVCpeak in the upright-seated posture 
were significantly attenuated in the old compared to the young during both the PL 
(ΔLBFpeak: ~59%, P<0.05; ΔLVCpeak: ~65%, p < 0.05) and the AOC condition 
(ΔLBFpeak: ~59%, P<0.05; ΔLVCpeak: ~61%, p < 0.05). Additionally, the AOC had no 
effect on the PLM-induced hyperemic response in either the young or old group or in the 
two body postures. 
The slope of LVC over time for the first 9 s was significantly attenuated with age 
under PL conditions in both the supine (young: 0.63 ± 0.10 ml/min/mmHg; old: 0.28 ± 
0.06 ml/min/mmHg; p < 0.05; Figure 4.3A) and upright-seated postures (young: 0.98 ± 
0.12 ml/min/mmHg; old: 0.32 ± 0.07 ml/min/mmHg; p<0.05; Figure 4.3B), as well as 
during the AOC condition (young supine: 0.68 ± 0.11 ml/min/mmHg; old supine: 0.28 ± 
0.05 ml/min/mmHg; young upright-seated: 1.09 ± 0.14 ml/min/mmHg; old upright-
seated: 0.34 ± 0.078 ml/min/mmHg; p < 0.05 between groups for a given body posture; 
Figure 4.3A and B). In the young, the upright-seated posture increased the PLM-induced 
rapid vasodilatory response during both the PL and AOC conditions (p < 0.05), with no 
change in the old. However, AOC supplementation had no effect on the rapid 
vasodilatory response to PLM in either the young and old group or in the two body 
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postures. 
The young exhibited a significant vasodilatory reserve capacity in both the PL and 
AOC conditions (Figure 4.4). However, the AOC had no effect on the magnitude of the 
vasodilatory reserve (PL: 4.1 ± 0.9 ml/min/mmHg, AOC: 3.8 ± 1.0 ml/min/mmHg, p = 
0.77). The old lacked a vasodilatory reserve capacity in the PL conditions and the AOC 
was unable to augment it (PL: 0.0 ± 0.5 ml/min/mmHg, AOC: 0.3 ± 0.7 ml/min/mmHg, p 
= 0.53), resulting in a significantly attenuated vasodilatory reserve capacity under both 
conditions compared to the young (p < 0.05). 
Discussion 
Utilizing the PLM model, a noninvasive measure of NO-mediated vasodilation, 
and the acute administration of an AOC, this study sought to determine the role of 
oxidative stress in the age-associated attenuation of lower limb vascular function. In 
agreement with previous findings, the hyperemic response to PLM was attenuated in the 
old, who remained unresponsive to the upright-seated posture, as evidenced by the 
absence of a vasodilatory reserve capacity. Although the old subjects exhibited greater 
inflammation than the young, lipid peroxidation was similar while plasma protein 
carbonyl levels tended to be higher in the old compared to the young. The AOC 
significantly improved antioxidant status in the young and old, significantly attenuating 
lipid peroxidation and ameliorating the tendency for higher protein oxidation in the old. 
However, the AOC had no effect on the vasodilatory response to PLM in either group or 
posture. Furthermore, both the vasodilatory reserve capacity and the rapid vasodilatory 
response in the upright-seated posture, previously documented to reflect additional 
markers of NO-mediated vasodilation, remained suppressed in the old subjects. 
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Therefore, vascular dysfunction persists in older adults despite an AOC-induced increase 
in antioxidant status and attenuated oxidative stress, questioning the role of redox balance 
in the apparent age-related decrease in NO bioavailability in the lower limbs. 
Free Radicals, Antioxidants, and Redox Balance 
In typical healthy conditions, intravascular cell free radical production is opposed 
by enzymatic and nonenzymatic antioxidant defenses, limiting the impact of free 
radically-mediated oxidizing reactions. Indeed, in young healthy individuals, this balance 
between pro- and antioxidant forces allows oxidants to act as intracellular signaling 
molecules while preventing oxidant levels from increasing to a point that could cause 
significant oxidative stress and cellular damage (6, 13, 20, 35, 37). Perhaps initiated, or at 
least perpetuated, by inflammation, when this redox balance is tipped in favor of pro-
oxidant forces, damage to proteins, DNA, and second messengers (i.e., oxidative stress) 
may lead to cellular dysfunction and/or apoptosis (21, 37). One such molecule is O2-, a 
free radical produced in vascular cells by the activation of NAD(P)H oxidase, xanthine 
oxidase, mitochondrial respiration, and uncoupled endothelial nitric oxide synthase 
(eNOS) (6, 37). O2- reacts rapidly with NO to form peroxynitrite (ONOO-), decreasing 
NO bioavailability and impairing vasodilation (26, 37, 42). Therefore, in individuals with 
elevated oxidative stress, decreasing free radicals may improve vascular function.  
Delivery of an AOC, as utilized in this study, including Vitamins C and E, and 
alpha-lipoic acid, should assist in counteracting the negative consequences of excess free 
radicals and sustain a healthy redox balance. Vitamin C scavenges free radicals, such as 
O2- and the hydroxyl radical (OH), by donating an electron and proton to form a reduced, 
nonradical product (12, 37). Decreasing the concentration of free radicals has been 
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demonstrated to limit the oxidation of Tetrahydrobiopterin (BH4), an important eNOS 
cofactor, thereby decreasing eNOS uncoupling and leading to greater NO bioavailability 
(2, 5, 26, 37). Additionally, Vitamin C inhibits LDL lipid peroxidation by vascular cells 
by scavenging protein radicals that initiate this process (4, 37). Vitamin E is a lipid 
soluble antioxidant that tends to localize to lipoproteins and cell membranes. As such, 
Vitamin E is the major antioxidant scavenger of lipid-derived peroxyl radicals, leading to 
the formation of a product that is nearly nonreactant (36, 37). In addition to attenuating 
lipid peroxidation, Vitamin E can also scavenge ONOO- to form nonradical products, the 
combination of which acutely decreases the concentration of free radicals (36, 37). 
Finally, alpha-lipoic acid acts both as a direct antioxidant, by quenching hydroxyl and 
hypochlorous radicals, and also in the chelation of redox active metals (30, 34). 
Additionally, alpha-lipoic acid has been documented to decrease O2- levels and improve 
NO-mediated vasodilation, likely achieved through its reduced form, dihydrolipoic acid 
(16, 30, 34). In the current study, the combination of Vitamin C and E and alpha-lipoic 
acid in the AOC significantly improved antioxidant status in both the young and old 
(Figure 4.1), significantly attenuated lipid peroxidation in both young and old, and 
ameliorated the tendency for higher protein oxidation in the old. 
Oxidative Stress and Vascular Function with Age 
Previous research has demonstrated that vascular function is attenuated in the old 
compared to the young, and that this decrement can be attributed to oxidative stress. 
Intra-arterial infusion of Vitamin C into the brachial artery of older humans improves 
endothelium-dependent vasodilation, whether induced by increasing wall shear stress (10, 
19) or by acetylcholine infusion (38, 39), with no effect in young subjects. However,
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these studies did not directly measure the oxidant/antioxidant status of the subjects, and 
rather assumed that the older individuals possessed vascular oxidative stress, given that 
antioxidant supplementation improved their vascular function. In a study utilizing the 
same oral AOC supplementation as the current investigation, Wray et al. (2012) 
measured blood markers of oxidant/antioxidant status, finding that serum thiobarbituric 
acid reactive substances (TBARS), a measure of blood born oxidants similar to MDA, 
were elevated at baseline in the old compared to the young (44). Interestingly, the old 
also demonstrated elevated FRAP compared to the young, perhaps suggesting that in this 
group, antioxidants were increased in response to elevated oxidants. Despite this attempt 
to “rebalance” pro and antioxidant forces, endothelium-dependent vasodilation in the 
brachial artery, assessed by FMD, was attenuated in the old compared to the young, and 
rescued after AOC supplementation. Finally, Donato et al. (2007) measured both brachial 
artery FMD and markers of oxidative stress and antioxidant capacity from arterial and 
venous endothelial cells harvested from the same subjects (7). The results revealed that 
older subjects had decreased endothelium-dependent vasodilation that was inversely 
related to levels of nitrotyrosine, a marker of protein oxidation. NAD(P)H oxidase was 
also elevated in the venous endothelial cells of the old men, while, similar to the current 
study, there was no evidence of an increase in endogenous antioxidants between the 
young and old groups (7). In combination with the current data (Figures 1-4), these 
findings reveal highly variable findings in terms of pro- and antioxidant levels with age, 
but consistent evidence of vascular dysfunction, which, until now, has predominantly 
been assessed in the upper limb. 
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Antioxidants and Vascular Function in the Leg with Age 
 Although the old subjects in this study had greater inflammation than the young 
(IL6 and CRP), lipid peroxidation (MDA) was similar, while evidence of protein 
oxidation (protein carbonyls) tended to be higher in the old compared to the young 
(Figure 4.1). Therefore, despite the preponderance of evidence indicating that advancing 
age is associated with oxidative stress, in the current group of healthy older men such a 
finding was not so clear-cut. However, as expected, the AOC significantly improved 
antioxidant status in the young and old, significantly attenuating lipid peroxidation, and 
ameliorating the tendency for higher protein oxidation in the old. 
 The hemodynamic findings from the current investigation agree with previous 
research demonstrating an attenuated PLM-induced vasodilation with age (14, 15, 28, 
40). In fact, here the NO component of PLM-induced vasodilation has been assessed 
utilizing three analysis techniques: the magnitude of the ΔLVCpeak (Figure 4.2), the rapid 
vasodilatory response (Figure 4.3), and the vasodilatory reserve capacity (Figure 4.4) (14, 
40). All of these techniques indicate that NO bioavailability is decreased with age as 
assessed by the PLM model. More specifically, in the PL condition; 1) the ΔLVCpeak in 
the supine posture was attenuated with age (Figure 4.2B); 2) augmenting FPP with the 
upright-seated posture increased the ΔLVCpeak in the young with no change in the old 
(Figure 4.2D), resulting in the absence of a vasodilatory reserve capacity with age (Figure 
4.4); and 3) while the slope of LVC over time increased in the young during augmented 
FPP, the rapid vasodilatory response did not change in the old (Figure 4.3). Finally, of 
significant importance, none of these observations were impacted by acute AOC 
supplementation. These assessments all indicate that NO bioavailability is attenuated in 
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this group of older subjects, despite less than obvious evidence of oxidative stress and 
clear impact of the AOC, questioning the direct role of redox balance in the apparent age-
related decrease in NO bioavailability in the lower limbs. 
The list of possible alternative mechanisms responsible for the diminished 
vascular function in the older subjects includes decreased eNOS content and/or 
phosphorylation, eNOS uncoupling due to decreased BH4 levels, and eNOS inhibition 
resulting from augmented caveolin-1 binding at the endothelial cell plasma membrane, 
among others. Interestingly, previous research has documented that eNOS protein content 
is preserved with age, while eNOS phosphorylation tends to increase (8, 29), the 
combination of which would augment NO bioavailability unless there was another 
deficiency. However, eNOS protein content and phosphorylation is only part of the 
equation. In the absence of BH4, eNOS becomes uncoupled and produces O2- rather than 
NO, a process that is exacerbated by uncoupled eNOS phosphorylation (22, 32). While 
decreased BH4 levels have been associated with aging and vascular dysfunction (11, 17, 
27), and it is possible that the older subjects in our study had decreased BH4 and 
increased eNOS uncoupling, any resulting increase in free radical production should have 
been quenched by the AOC, leading to an improvement in vascular function. As this was 
not the case, it is unlikely that eNOS uncoupling is responsible for the age-related 
attenuation in vascular function. Finally, in the inactive state eNOS binds to caveolin-1 
on the endothelial cell plasma membrane, a bond that must be broken in order for eNOS 
to become activated (18, 22, 32). It is possible that the age-associated increase in 
caveolin-1 (18, 45) prevents eNOS from being released into the cytosol where it can be 
stimulated to produce NO. Certainly, additional research is warranted to determine the 
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mechanisms by which PLM-induced vasodilation is attenuated with age. 
Conclusion 
The current investigation corroborates earlier reports that PLM-induced 
vasodilation, an indication of NO bioavailability, is attenuated with age, and extends 
these previous findings by demonstrating that the attenuation of NO-mediated 
vasodilation in the lower limbs of old subjects may not be a direct consequence of altered 
redox balance. Therefore, further research is warranted to elucidate the mechanisms 
responsible for the clearly diminished vascular function of the lower limbs with age. 
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Table 4.1 Subject characteristics 
BMI, body mass index; CFA diameter, common femoral 
artery diameter; HDL, high density lipoprotein cholesterol; 
LDL, low density lipoprotein cholesterol; WBC, white 
blood cell; CRP, C-reactive protein; IL-6, interleukin 6. #p 
< 0.05 compared to the young. Values are mean ± SEM. 
n (% Female)
Age (y) 22 ± 1 72 ± 2#
Height (cm) 172 ± 4 169 ± 3
Weight (kg) 68 ± 5 79 ± 5#
BMI (kg/m2) 23 ± 1 27 ± 1#
Thigh Vol (dL) 60 ± 7 54 ± 5
CFA diameter (cm) 0.83 ± 0.04 0.91 ± 0.05
Glucose (mg/dl) 71 ± 2 78 ± 3#
Cholesterol (mg/dl) 170 ± 14 204 ± 15#
Triglycerides (mg/dl) 96 ± 30 109 ± 15
HDL (mg/dl) 49 ± 4 54 ± 5
LDL (mg/dl) 106 ± 10 122 ± 10
Haemoglobin (g/dl) 14.9 ± 0.4 14.7 ± 0.3
WBC (K/ul) 5.4 ± 0.3 5.5 ± 0.5
Neutrophil (K/ul) 2.8 ± 0.2 3.1 ± 0.4
Lymphocyte (K/ul) 2.0 ± 0.2 1.6 ± 0.2#
Monocyte (K/ul) 0.49 ± 0.03 0.48 ± 0.05
CRP (ηg/ml) 469 ± 70 1314 ± 243#
IL-6 (pg/ml) 0.69 ± 0.06 3.00 ± 0.66#
Activity counts/min 163 ± 22 126 ± 16
Steps/day 6690 ± 863 5279 ± 634
#p<0.05 compared to young
Table 1:  Subject Characteristics
Young Old































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.1 Blood markers of pro- and antioxidant status. The difference in pro- and 
antioxidant blood markers between groups and under placebo (PL) and antioxidant 
cocktail (AOC) conditions. The AOC significantly increased the antioxidant markers 
Vitamin C and the ferric reducing ability of plasma (FRAP), and decreased the oxidant 
marker malondialdehyde (MDA) in both young and old subjects compared to PL. Young 
n = 15, old n = 17. * p < 0.05 compared to PL. Values are mean ± SEM. 
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Figure 4.2 Passive leg movement (PLM)-induced change in leg vascular conductance. 
Second-by-second tracing of leg vascular conductance (LVC, ml/min/mmHg) at baseline 
(BL) and throughout 60 s of PLM in the supine (A) and upright-seated (C) postures under 
placebo (PL) and antioxidant cocktail (AOC) conditions. Dashed line at 0 s indicates the 
start of 60 s of PLM. The PLM-induced peak change in LVC from baseline (ΔLVCpeak, 
ml/min/mmHg) was significantly attenuated in the old compared to the young in the 
supine (B) and upright-seated (D) postures in both the PL and AOC conditions. Young n 
= 15, old n = 17. There was no difference between PL and AOC in either group or body 
posture. #p < 0.05 compared to the young; †p < 0.05 compared to supine posture. Values 


















































Figure 4.3 Passive leg movement (PLM)-induced rapid vasodilatory response. The 
slopes calculated for the increase in the leg vascular conductance (LVC, ml/min/mmHg) 
over time (9 sec) display an attenuated rapid vasodilatory response in the old in both the 
supine (A) and upright-seated (B) postures, with no effect of the antioxidant cocktail (PL 
= placebo, AOC = antioxidant cocktail). Young n = 15, old n = 17. There was no 
difference between PL and AOC in either group or body posture. #p < 0.05 compared to 


































Figure 4.4 Passive leg movement (PLM)-induced vasodilatory reserve capacity. The 
difference in the PLM-induced peak change in leg vascular conductance (∆LVCpeak, 
ml/min/mmHg) between the supine and upright-seated posture (vasodilatory reserve 
capacity) in the young (n = 15) compared to the old (n = 17) under both placebo (PL) and 
antioxidant cocktail (AOC) conditions. There was no effect of the AOC in either group. 




The overall objective of this dissertation was to better understand alterations in 
vascular function with age in healthy humans by utilizing the PLM model, an assessment 
of predominantly NO-mediated vasodilation. Specifically, we examined the impact of 
aging on vascular function in women, the effect of greater physical activity and fitness 
levels on vascular aging, and the impact of acute antioxidant supplementation on vascular 
function with age. Collectively, by providing mechanistic insight, this research sought to 
identify strategies to improve vascular health, thereby lessening the adverse 
cardiovascular effects of human aging. 
Results from the first study support previous findings that PLM-induced 
vasodilation is attenuated with age, and extend these observations to include women. 
Additionally, increasing FPP by moving from the supine to the upright-seated posture, 
which magnifies the role of NO in both the rapid and overall vasodilatory response, 
revealed a vasodilatory reserve capacity in young women, but not their old counterparts. 
These findings imply that NO bioavailability is attenuated with age in women, and add 
additional support to the utility of the PLM model as an assessment of NO-mediated 
vascular function across the human lifespan. 
Study two again supports previous findings that aging has a deleterious effect on 
vascular function in otherwise healthy, sedentary humans, and adds to the literature by 
demonstrating that higher levels of physical activity and fitness can partially restore, or 
protect against, this age-associated decrease in PLM-induced vasodilation. The 
observation that the upright-seated ΔLVCpeak, PLM-induced vasodilatory reserve 
capacity, and rapid vasodilatory reserve capacity are predominantly NO dependent in the 
young suggests that the attenuated vascular function with age is due to decreased NO 
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bioavailability, which can be somewhat protected by increasing levels of physical activity 
and fitness with advancing age. 
The third study in this dissertation demonstrated that despite increased antioxidant 
capacity in both young and old subjects after ingestion of an oral antioxidant cocktail, 
this improved redox balance did not lead to augmented vascular function in either group. 
Therefore, the decrease in NO-mediated vasodilation in the lower limbs of old subjects 
may not be a direct consequence of oxidative stress. Further research is warranted to 
elucidate the mechanisms responsible for the clearly diminished vascular function of the 
lower limbs with age. 
Collectively, this research has expanded the literature by further characterizing 
age-associated declines in vascular function to include women and provided insight into 
the effects of physical activity and redox balance on the vasodilatory response with age. 
As decreased NO bioavailability and the subsequent attenuation in vascular function are 
linked to increased CVD risk and greater prevalence of morbidity and mortality, the 
methods developed and overall conclusions garnered from this dissertation have 
important implications for improving health and quality of life throughout human aging. 
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